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Abstract 
 
Transient gene expression (TGE) is a rapid method for generating recombinant 
proteins in mammalian cells, but the volumetric productivities for secreted proteins in 
transiently transfected CHO DG44 cells are typically more than an order of magnitude 
lower than the yields achieved with recombinant CHO-derived cell lines. The goals of the 
thesis are to identify the limitations to higher TGE yields in CHO DG44 cells and to find 
possible solutions to overcome the problems. Initially an attempt was made to enhance 
TGE production by increasing the amount of transfected plasmid DNA. However, this 
approach did not result in increased recombinant protein levels; on the contrary, 
transfection with an excess of plasmid DNA (> 1.25 μg/ml) had a negative impact on 
transgene mRNA levels and protein production. Moreover, it was also observed that 
recombinant protein yield was strongly dependent on the mRNA level. Therefore, three 
strategies aimed at increasing the amount of transgene mRNA were investigated. For the 
first approach, transfected cells were exposed to hypothermic conditions during the 
production phase. It was already known that lower temperatures increase protein 
production several fold in recombinant CHO DG44-derived cell lines. The second strategy 
involved the treatment of transfected cells with valproic acid, a histone deacetylase 
inhibitor that reduces the effects of gene silencing. The third approach aimed to increase 
transgene mRNA levels by overexpressing transcription factors and growth factors. With 
the first two strategies recombinant antibody yields of 60-80 mg/L were achieved whereas 
the untreated control transfections produced only 5-10 mg/L. Combination of the two 
strategies led to the production of 90 mg/L of antibody. Moreover, in the treated cultures, 
the steady-state level of transgene mRNA was 3-5 times higher than in the untreated 
cultures and remained stable up to 6 days post-transfection. Using the third approach, the 
increase in recombinant protein production was moderate and transgene mRNA amounts 
were only 2-fold higher in treated samples compared to the control. When specific proteins 
such as c-fos, c-jun, NF-kB, and acidic fibroblast growth factor (aFGF) were 
overexpressed the recombinant antibody production was 20 mg/L compared to 5 mg/L for 
the control transfection. Overexpression of either a transcription factor or a growth factor 
in combination with treatment with valproic acid allowed the recombinant protein yield to 
reach 90 mg/L. However, the benefit of the overexpressed factors was minimal compared 
to the effect of valproic acid alone. In conclusion, it was demonstrated that the level and 
stability of transgene mRNA are important factors for increasing volumetric yields in 
transiently transfected CHO DG44 cells. Furthermore, three approaches aimed to increase 
mRNA amounts were tested. Exposure to hypothermic conditions and treatment with 
valproic acid were the two best strategies tested. Both are simple, cost-effective, and 
scalable making transient gene expression in CHO DG44 cells a feasible alternative for 
rapid production of gram amounts of recombinant protein.  
 
Key words: Mammalian cell culture, recombinant protein, transient gene expression, 
monoclonal antibody, hypothermia, histone deacetylase, transcription factor, growth factor 
 
  
Riassunto 
 
L’espressione genica transiente è un metodo rapido e semplice per generare, in cellule 
di mammifero, ogni tipo di proteina ricombinante. Tuttavia la produttività specifica e 
volumetrica in cellule CHO trasfettate transientemente è inferiore di almeno un ordine di 
grandezza rispetto a quella normalmente ottenuta con linee cellulari stabili. L’obiettivo 
della tesi è di identificare le limitazioni nella produzione transiente in cellule CHO DG44 e 
trovare possibili soluzioni per risolvere il problema. Inizialmente si è provato ad aumentare 
la produzione transiente aumentando la quantità di DNA usata per la trasfezione. Tuttavia, 
questo approccio non ha portato ad un aumento dei livelli di proteina prodotta; al contrario, 
trasfettare le cellule con un eccesso di DNA plasmidico (> 1.25 μg/mL) ha avuto un 
impatto negativo sui livelli di mRNA transgenico e sulla produzione di proteina. Inoltre si 
è anche osservato che la quantità di proteina prodotta era fortemente dipendente dai livelli 
di mRNA; perciò, sono state studiate tre diverse strategie per aumentare la quantità di 
RNA messaggero. Il primo approccio è consistito nell’esporre le cellule ad ipotermia 
durante la fase produttiva. E’ infatti noto che, in linee cellulari derivanti da cellule CHO, le 
basse temperature aumentano i livelli di proteina prodotta. La seconda strategia ha 
implicato il trattamento, post-trasfezione, delle cellule con acido valproico, un inibitore 
delle istone-deacetilasi in grado di ridurre gli effetti del silenziamento genico. Il terzo 
approccio ha previsto di aumentare i livelli di mRNA sovraesprimendo fattori di 
trascrizione e di crescita. Utilizzando le prime due strategie elencate si sono potuti 
raggiungere dei titoli di anticorpo ricombinante pari a 60-80 mg/L, mentre la coltura di 
controllo ha prodotto solo 5-10 mg/L; la combinazione delle due strategie ha permesso la 
produzione di 90 mg/L di proteina. Inoltre, nelle colture trattate, il livello di mRNA 
messaggero era 3-5 volte più alto che in quelle non trattate ed è rimasto stabile per oltre 6 
giorni dopo trasfezione. Con il terzo approccio, si è riscontrato un aumento della 
produzione di proteina ricombinante e di mRNA  transgenico alquanto moderato se 
paragonato a quanto ottenuto con le prime due strategie. Infatti nel caso di 
sovraespressione di proteine specifiche quali c-fos, c-jun, NF-kB e aFGF sono stati 
prodotti solo 20 mg/L di anticorpo. La combinazione della sovraespressione di questi 
fattori e il trattamento con acido valproico ha permesso di raggiungere nuovamente la 
produzione di 90 mg/L di proteina ricombinante. Tuttavia, il beneficio tratto dalla presenza 
dei fattori è stato minimo paragonato all’effetto dell’acido valproico in sé. Concludendo, si 
è dimostrato che il livello e la stabilità dell’mRNA transgenico sono fattori importanti per 
aumentare la produttività volumetrica in cellule CHO DG44 trasfettate transientemente; in 
aggiunta, sono stati testati tre approcci per aumentare la quantità di mRNA. L’esposizione 
delle cellule a condizioni ipotermiche o a acido valproico si sono rilevate essere le migliori 
strategie. Entrambe sono semplici da attuare, a basso costo, e scalabili: pertanto la loro 
utlizzazione potrebbe rendere l’espressione genica transiente una possibile alternativa per 
la rapida produzione di grammi di proteine ricombinanti. 
 
Parole chiave: colture di cellule di mammifero, proteina ricombinante, espressione 
genica transiente, anticorpo monoclonale, ipotermia, istone-deacetilasi, fattore di 
trascritione, fattore di crescita. 
  
 
Résumé 
 
L’expression génique transitoire est une méthode rapide et simple pour générer des 
protéines recombinantes dans des cellules de mammifères. Cependant la productivité 
spécifique et volumétrique des cellules transfectées transitoirement est inférieure d’au 
moins un ordre de grandeur à celle normalement obtenue en utilisant des lignées cellulaires 
stables. L’objectif de cette thèse est d’identifier les limitations de la production transitoire 
en cellules CHO DG44 et de trouver des solutions possibles pour résoudre ce problème. 
Dans un  premier temps, la quantité d’ADN utilisé pour la transfection  a été augmentée 
afin d’améliorer la production de protéine. Cependant, cette approche n’a pas permis 
d’augmenter la quantité de produit ; au contraire, transfecter les cellules avec un excès 
d’ADN (> 1.25 μg/mL) a eu un impact négatif sur la quantité d’ARN messager et sur la 
production de protéine. En outre il a aussi été observé que la quantité de protéine produite 
était dépendante de la quantité d’ARN transgénique. Par conséquent trois stratégies ont été 
formulées et étudiées pour augmenter la quantité d’ARN. Dans une première approche, les 
cellules en phase de production ont été exposées à des conditions d’hypothermie. Il est en 
effet connu, que lignées cellulaires dérivant des CHO, produisent plus de protéines 
recombinantes si elles sont cultivées à basse température. La deuxième stratégie a impliqué 
le traitement après-transfection des cellules avec de l’acide valproïque, un inhibiteur des 
histones deacetylases capable de réduire les effets du gene silencing. La troisième 
approche s’est basée sur la surexpression de facteurs de transcription et de croissance. En 
utilisant les deux premières stratégies indiquées, 60-80 mg/L d‘anticorps recombinant ont 
été produits, tandis que le contrôle n’a produit que 5-10 mg/L. La combinaison de ces deux 
stratégies a permis la production de 90 mg/L de protéine. De plus, dans les cultures 
traitées, la quantité d’ARN messager était 3 à 5 fois plus élevée que dans le contrôle et elle 
est restée stable pendant au moins 6 jours après la transfection. Avec la troisième stratégie, 
une faible augmentation de la production de protéine et de la quantité d’ARN a été 
détectée. En effet, quand c-fos, c-jun, NFkB ou aFGF ont été surexprimés, la production 
d’anticorps n’a été que de 20 mg/L seulement. La combinaison de la surexpression de ces 
facteurs avec le traitement à l’acide valproïque a permis de produire de nouveau 90 mg/L 
de protéine. Cependant, le bénéfice de la présence des facteurs a été minimal comparé à 
l’effet de l’acide valproïque seul. En conclusion, il a été démontré que la quantité et la 
stabilité de l’ARN messager sont des facteurs importants pour augmenter la productivité 
volumétrique et spécifique des cellules CHO DG44 transfectées transitoirement. En outre, 
trois approches pour augmenter la quantité d’ARN transgénique ont été testées. Le 
traitement des cellules avec des conditions d’hypothermie ou avec de l’acide valproïque se 
sont révélées être les meilleures stratégies. Toutes les deux sont simples, peu chères et 
peuvent être amplifiées à large échelle : c’est pourquoi leur utilisation permettrait à 
l’expression génique transitoire d’être une bonne alternative pour la production rapide de 
plusieurs grammes de protéines recombinantes.  
 
Mots clés: culture de cellules de mammifère, protéine recombinante, expression 
génique transitoire, anticorps monoclonal, hypothermie, histone-deacetylase, facteur de 
transcription, facteur de croissance. 
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Zusammenfassung 
 
Transiente Genexpression (TGE) erlaubt die schnelle Produktion von rekombinanten 
Proteinen in Säugetierzellen, wobei die volumetrische Produktivität im Vergleich zu 
genetisch modifizierten CHO-Zelllinien um einige Grössenordnung geringer ausfällt. Das 
Ziel dieser Arbeit ist es die einschränkenden Faktoren für die rekombinanten 
Proteinerträge in TGE in CHO-Zellen zu identifizieren und Lösungsmöglichkeiten hierzu 
zu finden. Zunächst wurde versucht die Produktivität in TGE durch eine erhöhte Menge an 
transfizierter DNA zu steigern. Dieser Ansatz war allerdings nicht erfolgreich und führte 
im Gegensatz zu einer Verringerung der transgenen mRNA Levels und der rekombinanten 
Proteinproduktion bei Transfektionen mit > 1.25 μg/ml Plasmid DNA. Überdies wurde 
beobachtet, dass der Ertrag an rekombinantem Protein stark vom Niveau der 
entsprechenden mRNA abhing. Deswegen wurden drei Strategien getestet, um die Menge 
an transgener mRNA in den Zellen und damit die Produktivität zu erhöhen. Im ersten 
Ansatz wurden transfizierte Zellen hypothermischen Bedingungen während der 
Produktionsphase ausgesetzt. Es war bereits bekannt, dass niedrigere Temperaturen die 
Erträge von genetisch modifizierten CHO-Zelllinien um einiges erhöhen. Die zweite 
Strategie betraf das Hinzufügung von Valproinsäure in transfizierten Zellkulturen. 
Valproinsäure hemmt die Histonacetylase und verringert dadurch den Effekt der 
Genstilllegung. Das dritte Vorgehen zielte darauf ab, die transgenen mRNA Mengen durch 
die Überexprimierung von Transkriptions- und Wachstumsfaktoren zu erreichen. Mit den 
zwei erst genannten Methoden konnten Erträge von  60-80 mg/L rekombinanten 
Antikörpern erreicht werden, im Vergleich zu nur 5-10 mg/L in den unbehandelten 
Kontroll-Transfektionen. Die Kombination von Hypothermia und Valproinsäure steigerte 
die Erträge bis zu 90 mg/L Antikörper. Hinzu kam, dass im Durchschnitt 3-5 mal mehr 
transgene mRNA bis zu 6 Tagen nach der Transfektion in den behandelten Zellkulturen 
vorhanden war im Vergleich zu den Kontrollkulturen. Mit dem dritten Ansatz wurde nur 
eine gering Verbesserung der rekombinanten Erträge erzielt und behandelte Zellkulturen 
zeigte nur 2 mal soviel transgene mRNA wie die Kontrollkulturen. Wenn spezifische 
Faktoren wie c-fos, c-jun, NF-kB und aFGF (acidic fibroblast growth factor) 
überexprimiert wurden, wurden rekombinante Antikörpererträge von 20 mg/L erreicht, im 
Vergleich zu 5 mg/L in den Kontroll-Transfektionen. Die Überexpression eines 
Wachstumsfaktors oder eines Transkriptionsfaktors in Kombination mit Valproinsäure 
ergab Erträge bis zu 90 mg/L. Jedoch war der  Nutzen der überexprimierten Faktoren 
gering im Gegensatz zu der Wirkung von Valproinsäure. Zusammenfassend kann gesagt 
werden, dass die Menge und Stabilität der transgenen mRNA ein bestimmender Parameter 
für die volumetrische Produktivität  von TGE in CHO-Zellen ist. Darüberhinaus wurden 
drei Methoden getestet um die Menge an transgener mRNA in der Zelle und damit die 
Produktivität zu erhöhen. Die Kultivierung der Zellen unter Hypothermia und die 
Behandlung mit Valproinsäure waren die zwei erfolgreichsten Strategien. Diese beiden 
Methoden sind einfach, kostengünstig und skalierbar wodurch die TGE in CHO-Zellen 
eine attraktive Alternative, wird um rekombinante Proteine im Gramm-Masstab zu 
produzieren. 
 
Stichwörter: Säugetierzellkulturen, rekombinante Proteine, transiente Genexpression, 
monoklonale Antikörper, Hypothermia, Histoneacetylase, Transkriptionsfaktoren, 
Wachstumsfaktoren 
  
List of abbreviations 
 
CHO   Chinese hamster ovary (cells) 
CV  column volume 
CMV  citomegalovirus 
DHFR  dihydrofolate reductase 
GFP   green fluorescent protein 
ELISA  enzyme linked immunosorbent assay 
EF-1α   human elongation factor 1α 
HEK293  human embryonic kidney 293  
IgG  immunoglobulin G 
iHDAC  inhibitor of histone deacetylase 
NaBut   sodium butyrate 
PCV   packed cell volume 
pDNA  plasmid DNA 
PEI   polyethylenImine 
qRT-PCR  quantitative real-time polymer chain reaction 
SGE  stable gene expression 
TGE   transient gene expression 
VPA  valproic acid 
VPD  valpromide 
WPRE  Woodchuck hepatitis virus posttranscriptional element 
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Chapter 1 
Introduction 
 
 
 
1.1 Introduction to recombinant proteins 
 
Proteins are macromolecules located everywhere in cells: they are involved in cell 
growth, metabolism, organization, transport, motility (1). In multicellular organisms, 
proteins control the immune system, the neuron signalling, the growth and the 
differentiation of the whole organism (1). Mutation or the abnormal expression of proteins 
could be the origin of several diseases. Considering that the human genome contains more 
than 30,000 genes and that the number of proteins produced is even higher (2;3), the 
opportunities for pharmaceutical companies to develop new drugs are tremendously high 
(4). Therefore during the last decades, proteins became targets or candidates for 
development of new treatments.  
When proteins were first used as therapeutics, they were purified from animal or 
human sources. Examples include human growth hormone from human cadavers (5); 
insulin from pigs or cows (6); and human follicle stimulating hormone from the urine of 
females (7). However, the use of these sources has many concerns about the safety (5;6), 
the amount of product harvested and also the patients compliance. 
Fortunately, nowadays, products form animal origins are less in use. In fact since the 
late 1970’s, progress in biotechnology has allowed the synthesis of proteins from 
recombinant DNA using either prokaryotic or eukaryotic (yeast or mammalian) host 
systems. These proteins are termed “recombinant” (rec- or r-proteins) in order to 
distinguish them from endogenous proteins and to signify that they are produced from the 
expression of recombinant genes. The first rec-protein approved for human use was insulin 
produced in E. coli by Eli Lilly (Indianapolis, USA) in 1984 (8). The first rec-protein 
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produced in a eukaryotic host was tissue-type plasminogen activator (tPA) from Chinese 
hamster ovary (CHO) cells by Genentech in 1986 (9;10). By 2007 there were more than 
170 biopharmaceutical products approved by the Food and Drug Administration (FDA) in 
the USA, but this number is expected to increase in the coming years, considering that in 
2006 about 5,000 potential protein products were reportedly in discovery, preclinical 
studies and clinical trials (11;12).  
Among the host expression systems, the most widely used are E. coli and cultivated 
mammalian cells. About half the therapeutic protein products on the market are made in 
mammalian cells (9;11;12). Even if mammalian cell culture is more complicated and 
expensive than microbial cultivation, the former is often preferred because mammalian 
cells are capable of performing post-translation modifications (PTMs) of proteins, 
especially glycosylation (12;13). Other hosts capable of glycosylating proteins include 
yeast and cultivated insect and plant cells. The glycosylation in these hosts differs from 
that observed in mammalian cells (12); however, efforts are underway to “humanize” the 
glycosylation in these non-mammalian hosts (14-16). In 2007 the FDA approved the first 
biopharmaceutical produced in insect cells for use in humans (11). Alternative hosts 
include transgenic animals and plants, but these are still be in the development phase (12). 
 
Chapter 1 – Introduction 
 3
1.2 Recombinant protein production in mammalian cells 
 
Most of the mammalian cell-derived rec-proteins for clinical applications are produced 
in immortalized CHO cells, but other cell lines such as the mouse myelomas NS0 and 
Sp2/0 and human embryo kidney (HEK293) and baby hamster kidney (BHK-21) cells are 
also approved for production (9). The recombinant DNA is delivered to cells either by 
mechanical, chemical, or biological methods. Once it reaches the nucleus it can either be 
integrated into the genome or remain as an episomal DNA element until it is degraded. 
Alternatively, RNA virus vectors that replicate in the cytoplasm such as Semliki forest 
virus and vaccinia virus have been used for transient rec-protein production (17-19). 
 
 
1.2.1 Stable gene expression (SGE) 
 
The production of rec-proteins for the pharmaceutical market is based on the 
constitutive expression of the recombinant gene following the gene’s integration along 
with a selectable gene into the cell’s genome. Cells having undergone a gene integration 
event are genetically selected for the selection marker from the transfected cell population 
to generate clonal recombinant cell lines. The clonal cell lines with the desired phenotype 
for protein expression and cell growth are used for protein production. 
Advantages of this process are:  
I. all cells in the culture are expressing the transgene;  
II. the recombinant DNA is replicated along with the cellular genome and is therefore 
not lost during cell division;  
III. yields of rec-protein can be as high as 5 g/L in fed-batch cultures have been 
achieved.  
The main disadvantage of this approach is the time (6-12 months) and the cost 
required for the generation and characterization of the cell lines.   
 
 
1.2.2 Transient gene expression (TGE) 
 
As an alternative to SGE, rec-proteins can also be produced by TGE. Compared to 
SGE, it is simpler and faster.  
The advantages of TGE are:  
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I. there is no need to select for the cells with integrated recombinant DNA; 
II. the time frame from transfection to product purification is short (usually less than 3 
weeks);  
III. the simplicity and the versatility of the technique.  
TGE provides flexibility in construction of expression vectors; it also permits to 
change between a wide variety of host cell lines. Therefore, TGE is ideal for the rapid 
generation of multiple proteins or variants of a single protein (20) and for the production of 
quantities of rec-protein suitable for preclinical studies.  
The differences between TGE and SGE are summarized in Table 1.1. One of the  main 
differences is that genetic selection is not necessary for TGE. The recombinant DNA that 
reaches the nucleus following DNA delivery can either integrate or not into the host 
genome; in both cases it will be transcribed. The transfected cells are maintained as a batch 
or fed-batch culture for a defined period (up to two weeks) and then discarded. During the 
cultivation period the recombinant DNA can be degraded, transciptionally inactivated 
(silenced) via epigenetic pathways (21-24), or “diluted” at each cellular division so that the 
copy number of plasmid per cell decreases. 
 
 Table 1.1. Comparison of SGE and TGE. 
 SGE TGE 
Genetic selection Yes No 
Time from DNA to product 6-12 months up to 3 weeks 
Specific productivity (pg/cell/day) up to 50 below 10 
Volumetric productivity (g/L) up to 5 0.02 - 0.08 
Scalability up to 20,000 L up to 100 L 
Application Large scale production of therapeutic rec-protein 
Small-scale production 
of  protein for research 
 
The preferred hosts for TGE are CHO or HEK cells (25).  These cell lines are 
approved for therapeutic protein production and can grow in suspension under serum-free 
conditions (26-28). It has also possible to transiently produce rec-proteins in COS (African 
green monkey kidney) (29) and BHK cells (30).  
Secreted, intracellular, and membrane have been produced by TGE (20;25;31). For the 
production of intracellular proteins TGE is more suitable than SGE. In fact stable cell lines 
usually do not express intracellular recombinant proteins to high levels, unless controlled 
by an inducible promoter (32;33).  
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TGE has been shown to be scalable up to 100 L (27;28;34), however since the average 
amount of DNA per one million transfected cells is ~1 μg, the DNA cost is a factor that 
should be take into consideration when choosing TGE for a large scale process. 
Another major disadvantage of this technique compared to SGE is the moderate yield 
of rec-protein. The average yield for either secreted or non-secreted proteins is usually in 
the range of 10-80 mg/L depending on the cell line used and on the protein itself (25-28). 
Therefore, the main challenge of TGE is to close up the gap with SGE with regard to 
volumetric yield. The productivity of TGE depends on several factors including the gene 
delivery method, the medium, the culture environment, the host cell line, and the 
expression vector. Comparing HEK293 and CHO cell lines it appears that HEK293 cells 
produce higher amounts of protein than CHO cells (25). HEK293 cells also are also 
transfected more efficiently than CHO cells when using chemical DNA delivery agents. 
Recently, a fed-batch TGE process in HEK 293 cells yielded a volumetric productivity of 1 
g/L of a monoclonal antibody (35). Thus, for this cell it is possible to achieve by TGE the 
same volumetric yields obtained by SGE. For TGE in CHO cells, the upper limit for the 
volumetric yield has probably not been achieved and further developments will be 
necessary to increase transient rec-protein transient production from this host. Possibilities 
for further enhancements of TGE include the improvement of low-cost transfection 
methods and the use of high cell densities processes combined with feeding strategies: 
these approaches have been shown to be successful for TGE in HEK293 cells (36-38). 
Additional stategies include genetic modification of the host (39;40); decreasing of the 
epigenetic regulation of the host cell (41-43) and cell cycle arrest during the production 
phase (44;45). Some of the characteristics of TGE are summarized in Table 1.2 and 
explained in more detail in this chapter. 
 
Table 1.2.  Summary of TGE characteristics. 
Host cells used CHO, HEK, COS, BHK 
Categories of proteins produced Secreted, intracellular, membrane  
Amount of DNA per million of cells About 1 μg 
Vectors used for TGE Both non-viral and viral 
DNA delivery methods for TGE Chemical delivery (usually) 
Advantages Fast, simple, versatile 
Disadvantages Low yields and high cost of DNA 
Key factors for TGE Host cell, gene delivery method, medium, vectors,  
Highest titer 1 g/L in HEK293 cells 
Possible improvements  
High cell densities transfection, feeding strategies, 
genetic modification of the host, enhanced transcripton, 
cell cycle arrest during production 
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Currently, there are no therapeutic rec-proteins on the biopharmaceutical market that 
are produced by TGE. This is mainly due to the low yields from TGE process and the high 
cost of plasmid DNA, limiting the production of enough protein to meet market needs. 
There are also concerns about the heterogeneity of the product from batch to batch. 
However, it should be mentioned that some PTMs, like glycosylation, are dependent on the 
cell culture process (46;47), therefore it is also possible to find variability from batch to 
batch and within batches in SGE-derived products.  
 
 
1.2.3 Vectors used for TGE 
 
Non-viral vectors are the most commonly used ones in TGE. These plasmid vectors 
usually contain a strong, constitutive promoter, optimized mRNA processing and 
translational signals (i.e. Kozak sequence, mRNA cleavage and polyadenylation signals), 
and prokaryotic elements for plasmid amplification and selection in bacteria (48). The 
transcriptional promoters used for TGE are mainly from viral sources but cellular 
promoters are also employed. The immediate early cytomegalovirus (CMV) 
promoter/enhancer from mouse (mCMV) or human CMV (hCMV) and the simian virus 40 
(SV40) early promoter/enhancer are the most frequently used elements (25;48), but the 
adenovirus major late promoter and the Rous sarcoma virus promoter are alternatives (48). 
Among the cellular promoters, that from the human elongation factor 1-α (EF-1α) gene has 
been shown to be as active as the viral promoters listed above in terms of recombinant 
gene expression (25;49). Other elements such as an intron can be added. The presence of 
an intron in the 5’ untranslated region of the transgene has been shown to increase 
recombinant protein production (50).  
Plasmid DNA for TGE is usually produced by amplification in bacteria and purified 
using ion exchange chromatography. To achieve a high transfection efficiency, purified 
pDNA should not contain contaminants traces of bacterial RNA or protein, since these 
components may interfere with DNA delivery (51).  
 
 
1.2.4 Chemical gene delivery 
 
Gene delivery can be performed using mechanical, chemical, or biological methods. 
The mechanical methods include microinjection (52) and electroporation (53). The 
chemical transfection methods depend on complex formation between positively charged 
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molecules such as calcium phosphate (CaPi) (54-57), lipids (58;59), or cationic polymers 
(60) and negatively charged DNA. Biological gene delivery is usually performed with 
viruses, especially retroviruses (61;62). Chemical delivery is the most widely chosen 
method for TGE (25), especially with low cost compounds such as calcium phosphate 
(34;54;56;57) and polyethylenimine (PEI) (26;27;60;63). 
CaPi transfections have been performed with different cell lines at volumetric scales 
up to 100 L (34). The DNA/CaPi co-precipitate is  produced by mixing CaCl
2 
and DNA 
and then adding phosphate. Thus the DNA is entrapped in the CaPi precipitate (57;64;65).  
After addition to the culture and binding to the cell surface, the complexes enter cells by 
phagocytosis (66). After disruption of precipitate-containing vesicles, the DNA is released 
in the cytoplasm and probably enters the nucleus when the nuclear membrane is disrupted 
during mitosis (57;67;68). The major disadvantage of this method, however, is its reliance 
on serum in the culture medium at the time of transfection (69).  
Cationic lipids have been shown to complex with DNA and enter cells, therefore they 
are widely used both in vivo and in vitro to deliver drugs or macromolecules (59;61;70). It 
was a common belief that liposomes were able to delivery their “cargo” by fusing with 
phospholipids within cell membrane. Now, it has been shown that only a small percentage 
of liposomes enter cells in this way. Most of them are internalized through endocytosis 
(61). However, the main disadvantage of these lipid-based chemicals is the high cost; 
therefore they are not a suitable strategy for large scale transfection.  
Polycations such as PEI (60;71), DEAE-dextran (72), or polylysine (73;74) are widely 
used for efficient gene delivery to mammalian cells. Among them, PEI is the most 
commonly employed in TGE due to its low cost and high efficiency for DNA delivery (25-
27;36;39;63;75). Due to its positive charge, PEI is able to interact with DNA to form 
positively charged complexes that bind to the negatively charged proteoglycans present on 
the surface of the cell membrane and enter the cell by endocytosis (61;76). Many theories 
have been proposed about the escape of the complexes from the endosome (60;61;77), 
however the “proton sponge” mechanism (60;78) is still the most accepted one. PEI is a 
polycation containing amino groups with buffering capacity. The degree of protonation of 
the amine increases from 20 to 45% as pH decreases from 7 to 5 (78). Endosomes are 
usually acidified by the cellular ATPases present on the membrane of these organelles. The 
influx of protons is accompanied by an influx of Cl- ions to neutralize the positive charge. 
This ion influx increases the osmolarity in the endosomes. Subsequently, a water influx 
causes swelling and disruption of the endosomes and the release of the PEI-DNA 
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complexes. Once in the cytosol, the fate of PEI-DNA complexes, especially their delivery 
to the nucleus, is not fully understood. However, DNA can be released from the complexes 
in the presence of a competing polyanion, such as RNA or DNA, present in the cytoplasm 
or nucleus (51). The main advantage of PEI-mediated transfection is that it is efficient in 
serum-free medium (27). In fact, the presence of serum may have deleterious effect on 
transfection efficiency. There is evidence that protein in the medium disrupts PEI-DNA 
complexes and decreases transfection efficiency (Duhr and Wurm, unpublished data).  
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1.3 Research objectives 
 
Prior to the performance of the research described here, the highest yield of rec-protein 
produced in CHO cells by TGE was 10-20 mg/L (26;27). At the onset, the aim of this 
thesis was to determine some of the limiting factors in TGE in CHO cells and to propose 
strategies to solve the problem.  
Experiments showing that the transgene mRNA level and not the level of pDNA 
uptake is a limiting factor for TGE are described in Chapter 3. The amount of pDNA 
transfected did not correlate with transgene mRNA and rec-protein levels. However, 
transgene mRNA levels and rec-protein levels were shown to correlate. In the subsequent 
chapters experiments to develop three different strategies for enhancing transgene mRNA 
levels and TGE are described. 
TGE under hypothermic conditions is described in Chapter 4. It was shown that 
hypothermia is able to modify cell metabolism and also to increase transgene mRNA 
amounts relative to the control transfections at 37°C. The system is easily scalable and rec-
protein yields obtained were in the range of 60-80 mg/L.  
The effect of valproic acid (VPA), a histone deacetylase inhibitor, on TGE is 
described in Chapter 5. As in the previous chapter, the transgene mRNA levels were higher 
and more stable over time as compared to transfections at 37°C. The transient rec-protein 
yield reached 90 mg/L when VPA was combined with hypothermic treatment. 
In Chapter 6 the possibility of enhancing transcription by overexpression of either 
transcription or growth factors was explored. Some factors increased rec-protein 
production by ~3-fold and mRNA levels by 2-fold relative to the control transfection, 
however IgG titers were lower compared to the ones obtained under hypothermic 
conditions or in the presence of VPA.  
Additional experiments describing the establishment of an inducible system for the 
overexpression of transcription factors in CHO cells are reported in the Appendix 1. 
Finally, the purification and partial characterization of the recombinant monoclonal 
antibody used as reporter protein in all the experiments is reported in Appendix 2.  
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Chapter 2 
Materials and methods 
 
 
 
2.1 Cell culture 
 
Suspension-adapted CHO DG44 cells (dhfr-/-) were routinely cultivated in ProCHO5 
medium (Lonza, Verviers, Belgium) supplemented with 0.68 mg/L hypoxanthine, 0.194 
mg/L thymidine, and 4 mM glutamine (SAFC Biosciences, St. Louis, MO) in orbitally 
250-mL square shaped bottles shaken at 110 rpm in a ISF-4-X incubator (Adolf Kühner 
AG, Birsfelden, Switzerland) as previously described (1). Temperature and humidity of the 
incubator were kept constantly at 37°C and 20%, respectively. Manual counting was 
performed with a Neubauer hemocytometer. Cell viability was assessed using the Trypan 
blue exclusion method. Biomass was determined by the packed cell volume (PCV) method 
using ValuPac tubes (Sartorius AG, Göttingen, Germany): cells were loaded in the tube 
and centrifuged at 2500 g for 1 minute as previously described (2). Under standard 
cultivation conditions at 37 °C, a cell density of 1 x 106 cells/mL was equivalent to a PCV 
of 0.175% for CHO DG44 cells (2). 
 
 
 
 
2.2 Transfection 
 
One day prior to transfection, cells were seeded at a PCV of 0.35% in the appropriate 
volume of fresh ProCHO5 in a square-shaped glass bottle. On the day of transfection, the 
cells were centrifuged at 800 rpm for 5 min and resuspended in fresh, supplemented 
ProCHO5 (if not otherwise specified) at 0.70% PCV. Transfections (if not otherwise 
specified) were performed in CultiFlask 50 tubes (Sartorius AG) (3). Each transfection was 
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performed in 5 mL of culture using 12.5 μg of DNA and 50 μg of linear 25 kDa PEI (4). 
The DNA and PEI were each diluted in 250 μL of 150 mM NaCl, mixed, and then allowed 
to stand for 10 min at room temperature prior to addition to the cells. The transfected 
cultures were incubated in a ISF-4-X incubator (Adolf Kühner AG) at 37 °C in 5% CO2 
and 85% humidity with agitation at 180 rpm (4). After 4 h, the cultures were diluted with 5 
mL of ProCHO5 with supplements (if not otherwise specified). For temperatures other 
than 37 °C, the cultures were maintained in an ISF-1-W incubator-shaker (Adolf Kühner 
AG) in the presence of 5% CO2 and 85% humidity. 
 
 
 
 
2.3 Plasmids 
 
2.3.1  pEGFP-N1 
 
pEGFPN1 expressing the enhanced green fluorescent protein (GFP) gene was 
purchased from ClonTech (Palo Alto, CA, USA) (Figure 2.1).  
 
 
 
 
 
Figure 2.1. Schematic diagram of pEGFPN1. The plasmid contains the human cytomegalovirus 
promoter (hCMV promoter), a multiple cloning site (MCS), the eGFP, the polyadenilation sequence 
from SV40 (SV40 PolyA) and the resistance to Kanamycin (KanR) for bacterial selection. 
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2.3.2 pEAK8-LH39, pEAK8-LH41, pKML and pKMH  
 
The expression vectors for the human IgG light (pEAK8-LH39 and pKML) and heavy 
chain (pEAK8-LH41 and pKMH) genes have been described previously (5;6) (Figure 2.2).  
        
 
Figure 2.2. Schematic diagrams of pEAK8 and pKMH/pKML. pEAK8 contains the elongation 
factor 1-α (EF1α) promoter fused with the EF1α intron, human growth hormone (hGH) polyA, 
Puromycin resistance (PuroR) for mammalian selection and Ampicillin resistance (AmpR) for 
bacterial selection. pKML/H contains the mouse cytomegalovirus promoter (mCMV promoter), 
EF1α intron, bovine growth hormone (BGH) polyA, Neomycin resistance (NeoR) for mammalian 
selection and AmpR for bacterial selection. 
 
 
 
2.3.3 pXLGHEK  
 
The IgG light and heavy chain cDNAs from pKML and pKMH and the GFP gene 
from pEGFP-N1 were individually subcloned into pXLGHEK to produce pXLGHEK-RhLC, 
pXLGHEK-RhHC, and pXLGHEK-EGFP, respectively, as described (7;8) (Figure 2.3).  
pXLGHEK-ΔWPRE-RhLC and pXLGHEK-ΔWPRE-RhHC were generated through 
removal of the WPRE by restriction digestion of pXLGHEK-RhLC and pXLGHEK-RhHC, 
respectively, with BamHI and BglII followed by religation.  
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Figure 2.3. Schematic diagram of pXLGHEK-EGFP.  The plasmids contains inverted terminal 
repeats (ITR) before and after the mammalian expression cassette, the hCMV promoter, the intron 
from SV40, the eGFP, the Woodchuck hepatitis post-transcriptional regulatory element (WPRE), 
bGH polyA and additional sequences from adeno-associate viruses (AAV). 
 
 
 
2.3.4 pMYKEF1-puro  
 
pMYKEF1-puro and pMYKEF1-EGFP-puro have been described previously (9) 
(Figure 2.4).  
 
 
 
Figure 2.4. Schematic diagram of pMYKEF1-EGFP-puro. The plasmid the same elements 
described for pKML/pKMH except for the Neomycin resistance that was substituted with Puromycin 
resistance (PuroR). 
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2.3.5 Cold induced proteins 
 
The CIRBP and Rbm3 cDNAs were purchased from ImaGenes (ImaGenes GmbH, 
Berlin, Germany) and amplified by PCR with specific primers (see Table 2.1) to create a 
SpeI restriction site at the 5’ end and an EcoRI site at the 3’ end of the coding region. The 
amplified sequences were then ligated into pMYKEF1 vector, previously digested with 
SpeI and EcoRI in order to generate pMYK-CIRBP and pMYK-Rbm3, respectively. 
 
 
 
2.3.6 Transcription factors  
 
All cDNAs coding for transcription factors were purchased from ImaGenes GmbH, 
amplified by PCR with specific primers (see Table 2.1) to create a NotI restriction site at 
the 5’ end and an HindIII site at the 3’ end of the coding region, and cloned into pXLGHEK. 
For the NF-kB cDNA, a two-step cloning scheme was necessary due to the length of the 
gene. 
 
Table 2.1. Primers used for PCR amplifications of transcription factor cDNAs. 
Gene 5’- Primera 3’ - Primera 
CIRBP ACTAGTATGGCATCAGATGAAGGC GAATTCTTACTCGTTGTGTGTAGC 
Rbm3 GAATTCTCAGTTGTCATAATTGTC ACTAGTATGTCCTCTGAAGATGGA 
c-fos GCGGCCGCCATGATGTTCTCGGGCTTCA AAGCTTATCACAGGGCCAGCAGCGTGGG 
c-fosb AGGCGAATTCATGATGTTCTCGGG ACCGGGACACTTCGAACCTAGGTT 
c-jun GCGGCCGCCATGACTGCAAAGATGGAAA AAGCTTATCAAAATGTTTGCAACTGCTG 
NF-kB  GCGGCCGCCATGGCAGAAGATGATCCAT 
CTGACTTGGAAACTAGTGAACCAAAAC 
GTTTTGGTTCACTAGTTTCCAAAGTCAG 
AAGCTTACTAAATTTTGCCTTCTAGAGG 
CREB GCGGCCGCCATGACCATGGAATCTGGAG AAGCTTATTAATCTGATTTGTGGCAGTA 
Sp1 GCGGCCGCCATGAGCGACCAAGATCAC AAGCTTATCAGAAGCCATTGCCACTGAT 
Elk1 GCGGCCGCCATGGACCCATCTGTGACGC AAGCTTATCATGGCTTCTGGGGCCCTGG 
 
a The sequences are reported in the 5’ – 3’ sense. 
b The sequences reported are the primers used for cloning of c-Fos in the gas inducible plasmid, 
pWW192 (see Section 2.3.7) 
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2.3.7 Gas-inducible vectors   
 
pWW195 and pWW192 (Figure 2.6) were kindly provided by Dr. Wilfred Weber 
(ETHZ, Zürich, Switzerland) and they were previously described in literature (10). 
pWW192GFP was generated through removal of the SEAP cDNA and the internal 
ribosome entry site (IRES) from pWW192 by restriction digestion with EcoRI and NotI 
and cloning of the GFP gene after its recovery by restriction digestion from pMYKEF1-
EGFP-puro. 
The c-fos cDNA was amplified by PCR from pXLGHEK-c-fos. Specific primers 
(reported as c-fosb in Table 2.1) were used to create a EcoRI site at the 5’ and a HindIII site 
at the 3’ of the PCR product. The amplified cDNA was then ligated into pWW192 after 
digestion with EcoRI and HindIII. 
 
 
 
Figure 2.6. Schematic diagrams of pWW192 and pWW195.  pWW192 contains a promoter (Pair) 
composed by the A.Nidulans operon responsive to acetaldehyde and a minimal hCMV promoter, 
the sequence codifying for the secreted alkalyne phosphatase (SEAP), an internal ribosome entry 
site (IRES), a poly adenylation site (pA) and AmpR for bacterial selection. pWW195 expresses a 
constitutive SV40 promoter (SV40 prom), the sequence of the acetaldehyde responsive element 
(AlcR), a polyA site. 
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2.3.8 Summary of plasmid elements 
 
Table 2.2 reports the primary elements (promoters, introns, mammalian resistance and 
other sequences) present on the vectors used in this work. 
 
Table 2.2.  Primary transcriptional elements of the plasmids used in this study. 
Plasmid Promoter Intron Selection marker Other elements 
pEGFPN1 hCMV - - - 
pEAK8 EF-1α EF-1α Puromycin - 
pMYKEF1 mCMV EF-1α Puromycin - 
pKMH/pKML mCMV EF-1α Neomycin - 
pXLGHEK hCMV SV40 - WPRE and AAV ITRs  
pWW195 SV40 - - - 
pWW192 hCMVmin + OAlcR - - IRES 
 
 
 
 
 
2.4 Plasmid purification and quantification 
 
Plasmid DNA for transfection was purified using a NucleobondAX anion exchange 
column (Macherey-Nagel, Düren, Germany) according to the manufacturer’s protocol and 
stored in TE buffer (10 mM Tris-HCl, 1 mM EDTA, pH 7.4). The purified plasmid was 
quantified by UV absorbance at 260 nm. 
 
 
 
 
2.5 Nutrient and metabolite quantification 
 
After transfection, 500 μL aliquots of culture were centrifuged, and the supernatant 
was used to quantify the levels of glucose, glutamine, ammonium, and lactate using the RX 
Daytona chemistry analyzer (Randox Laboratories Ltd., Crumlin, UK). 
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2.6 Cell size analysis 
 
After transfection, 20 μL aliquots of culture were diluted with 10 mL of CasyTon 
solution (Innovatis AG, Durmersheim, Switzerland), and the mean cell volume and cell 
diameter were quantified with a Casy Counter (Innovatis AG). 
 
 
 
 
2.7 mRNA extraction and quantification 
 
At different times after transfections, 1 x 106 cells were collected by centrifugation and 
washed twice with sterile PBS. Total RNA was extracted using the GenElute mRNA kit 
(Sigma-Aldrich GbmH, Buchs, Switzerland) according to the manufacturer’s protocol. 
Samples were treated with 1 U of DNAse I (Invitrogen AG, Basel, Switzerland) for 15’ at 
room temperature, the enzyme was then inhibited by addition of EDTA and by heating. 
First-strand cDNA synthesis was performed from 1 μg of RNA with the M-MLV reverse 
transcriptase (Invitrogen AG) using oligo dT (New England Biolabs, Ipswich, MA) as the 
primer. Each reaction was diluted 10-fold in RNAse-free water for quantitative PCR. The 
oligonucleotide primers for the amplification (Table 2.3) of cDNAs were purchased from 
SAFC Biosciences (St. Louis, MO, USA).  
 
Table 2.3. Primers used for qPCR in this study. 
Gene 5’- Primera 3’ - Primera 
β-Actin GCTCTTTTCCAGCCTTCCTT GAGCCAGAGCAGTGATCTCC 
LC TGTCTTCATCTTCCCGCCA GCGTTATCCACCTTCCACTGT 
HC AAGGCTTCTATCCCAGCGACA GCATCACGGAGCATGAGAAG 
 
a The sequences are reported in the 5’ – 3’ sense. 
 
The samples from the first-strand cDNA synthesis were mixed with the appropriate 
oligonucleotide primer pair and the reaction mix from the Absolute qPCR SYBR Green 
ROX mix (Axon Lab AG, Baden-Dättwil, Switzerland) and amplified according to the 
manufacturer’s protocol. All experiments were performed on an ABI 7700 Real Time PCR 
instrument (Applied Biosystems, Foster City, CA, USA). All samples were analyzed in 
triplicate. Collected data were processed using SDS software (Applied Biosystems) to 
obtain Ct values. The comparative Ct method was used to calculate the relative quantity of 
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IgG light and heavy chain mRNAs as normalized to the quantity of β-actin mRNA 
(Equations 2.1, 2.2, and 2.3) (11). Non-transfected cells were used as calibrator.  
 
  
∆CT = Ct sample – CtHKG      (eq. 2.1) 
∆∆Ct = ∆Ct sample - ∆Ct calibrator     (eq. 2.2) 
Normalized mRNA levels = 2 -∆∆Ct    (eq. 2.3) 
 
Equations used for normalize mRNA levels. The delta Ct (∆CT) was calculated by subtracting 
the value of Ct obtained for the housekeeping gene to the value of Ct of the sample (eq. 2.1). To 
obtain the delta delta Ct (∆∆Ct) the ∆Ct of the calibrator was subtracted to the ∆Ct of the sample 
(eq. 2.2). The normalized mRNA levels were obtained by elevating 2 to the -∆∆Ct. 
 
 
 
 
 
2.8 Total DNA extraction from mammalian cells  
 
At different times after transfection, 1 x 106 cells were harvested and treated with 100 
U of DNAse I (Roche SA, Rotkreuz, Switzerland) for 15 min at 37°C. The enzyme was 
inhibited by addition of 25 mM of EDTA followed by heating at 65°C for 10 min. Pellets 
were frozen at -20°C and then thawed or directly treated with 500 μL of TENSK buffer for 
3 h at 50 °C as described (12). Total DNA was then extracted with 500 μL of 
phenol/chloroform/isoamyl alcohol (IAA) (24:25:1) (Sigma-Aldrich GmbH).  The aqueous 
phase was transferred to an Eppendorf tube and treated with 200 μg/mL of RNAse at 37 °C 
for 1 h. A second step of phenol/chloroform/IAA extraction was performed in order to 
remove the RNAse. Two volumes of cold 100% ethanol and 0.5 volumes of cold 7.5 M 
NH4Acetate were then added.  The DNA was allowed to precipitate overnight at -20 °C. 
After centrifugation, the DNA pellet was washed with 70% ethanol and resuspended in TE 
buffer. Total DNA was quantified by UV absorbance at 260 nm. 
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2.9 Quantification of plasmid copy number per cell 
 
DNA purified from mammalian cells was diluted with ultrapure milliQ water, mixed 
with Absolute qPCR SYBR Green ROX mix (Axon Lab AG) and amplified according to 
the manufacturer’s protocol. Primers used for amplification of the polyA region of 
pXLGHEK vector were reported in Table 2.4. A known amount of pXLGHEKEGFP plasmid 
quantified by UV absorbance was used to create a copy number standard curve.  
 
Table 2.4. Primers used for qPCR of the BGH polyA element in pXLGHEK. 
Target 5’- Primera 3’ - Primera 
BGH pA CTTCTAGTTGCCAGCCATCTGTT AGAATGACACCTACTCAGACAATGC 
 
a The sequences are reported in the 5’ – 3’ sense. 
 
 
 
 
2.10 Transfection efficiency analysis 
 
Transfection efficiency based on exogenous GFP expression was analyzed using a 
GuavaEasyCyte flow cytometer (Guava Technologies, Hayward, USA) with the Guava 
Express Plus assay. Data were processed with the Guava Cyto SoftTM software (Guava 
Technologies). 
 
 
 
 
2.11 GFP fluorescence quantification 
 
For GFP analysis, 100 μL of culture was lysed by addition of 1 volume of 1% Triton 
X-100 in PBS. After incubation at 37 °C for 1 h with agitation, the fluorescence was 
measured using a TECAN Saphire II plate-reading fluorometer (TECAN, Männedorf, 
Switzerland). GFP was excited at 485 nm with a bandwidth of 10 nm, and the emission 
fluorescence was measured at 515 nm with a bandwidth of 10 nm. 
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2.12 Recombinant IgG quantification 
 
IgG concentration was determined by sandwich ELISA using a goat anti-human kappa 
light chain antibody (BioSource, Lucerne, Switzerland) for capture and alkaline 
phosphatase-conjugated goat anti-human IgG (BioSource) for detection (13). 
 
 
 
 
2.13 Recombinant IgG purification 
 
Recombinant antibody was partially purified by affinity chromatography using 
Streamline Protein A (GE Healthcare, Uppsala, Sweden). A PolyPrep column (BioRad, 
Hercules, CA) containing Streamline Protein A was equilibrated with 5 column volumes 
(CVs) of 50 mM sodium phosphate (pH 7.0), and then 10 mL of the clarified culture 
medium was loaded. The column was washed with 10 CVs of 50 mM sodium phosphate 
(pH 7.0), and IgG was eluted with 2 CVs of 0.1 M sodium citrate (pH 3.0) and 
immediately buffered with 10% (v/v) 1 M Tris-HCl (pH 8.0). The neutralized eluate was 
desalted and concentrated, and the buffer was replaced with deionized water or 10 mM 
sodium phosphate pH 7.2 using a Microcon or Centricon centrifuge filter with 10 KDa cut 
off (Millipore, Bedford, MA, USA). 
 
 
 
 
2.14 Recombinant IgG deglycosylation 
 
The antibody was treated with PNGase F (QAbio, Palm Desert, CA) for 12 hours at 
37°C, according to the manufacturer’s protocol and analyzed on a 4-12% polyacrylamide 
gradient gel (Invitrogen) in reducing conditions. Proteins were visualized by Coomassie 
Blue staining.  
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2.15 Intracellular proteins extraction 
 
Three days after transfection, five millions of cells were harvested and centrifuged at 
13000 rpm for 5 min. Supernatant was discharged and pellets were washed three times 
with cold PBS 1x. Samples were then treated with M-PER Mammalian Protein Extraction 
Reagent (Pierce – Thermo Scientific, Rockford, IL) according to the manufacturer’s 
protocol and either immediately loaded on an SDS-PAGE gel or stored at -20°C. 
 
 
 
 
2.16 SDS-PAGE and Western Blot analyses 
 
TRIS-Glycine SDS-PAGE gels with different acrylamide concentrations were 
prepared and run using a Mini Protean 3 Cell system (BioRAD). Samples were mixed with 
2x sample buffer, boiled for 5 min and then electrophoresed at 100 V for the stacking gel 
and at 150 V for the separating gel buffer.  
After electrophoresis the gels were either stained with Coomassie Blue or transferred 
onto a PVDF membrane (Millipore) for immunoblotting. The transfer was done at 60 mA 
for 1 h at 4 °C. The membrane was then blocked with 10 mL of blocking solution for 1 h at 
room temperature (or overnight at 4 °C). The solution was discarded and the membrane 
was incubated for 1 h at room temperature (or overnight at 4 °C) with 10 mL of blocking 
solution containing the primary antibody (Table 2.6). The membrane was then washed 
three times with washing solution and incubated with the secondary antibody-HRP 
conjugated (Table 2.6) diluted in blocking solution. After two washes in washing solution, 
the membrane was treated with ECL reagent (GE Healthcare) and developed on Hyperfilm 
(GE Healthcare). 
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Table 2.6.  Primary and secondary antibodies used for Immunoblotting. 
Primary Antibody Secondary Antibody 
Target 
Protein Host Supplier 
Dilutio
n 
Supplier Dilution 
CIRBP 
Rabbit – 
polyclonal 
ProteinTech, IL, USA 1:200 Sigma, MO, USA 1:10000 
Rbm3 
Rabbit – 
polyclonal 
Scripps Research 
Institute, CA, USA (14) 
1:2000 Sigma, MO, USA 1:10000 
c-FOS 
Rabbit – 
polyclonal 
Calbiochem, CA, USA 1:1000 Sigma, MO, USA 1:10000 
aFGF 
Mouse – 
monoclonal 
Sigma, MO, USA 1:1000 Sigma, MO, USA 1:50000 
 
 
 
 
 
2.17 Buffers 
 
TENSK:  25 mM Tris pH 8.0 
10 mM EDTA  
200 mM NaCl 
1% SDS 
500 μg/ml Proteinase K 
 
TE:  10 mM Tris-HCl pH 7.4 
1 mM EDTA 
 
 
PBS 10x:  30 mM NaH2PO4• H2O 
70 mM Na2HPO4• 2H2O 
1.5 M NaCl 
 
 
Coomassie Blue Stain:  0.25% (w/v) Coomassie Blue R-250 
20% (v/v) isopropanol 
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Coomassie Blue Destain: 7% (v/v) acetic acid 
 
4x Separating Buffer for SDS-PAGE: 1 M Tris-HCl pH 8.8  
    
4x Stacking buffer for SDS-PAGE: 1.5 M Tris- HCl pH 6.8 
 
10x Running buffer for SDS-PAGE: 0.25 M Tris  
      1.9 M glycine 
      1% (w/v) SDS 
  
2x Loading buffer:  25% (V/V) 4x stacking buffer 
    20% (v/v) glycerol 
    0.5% (w/v) Bromophenol Blue 
    4% (w/v) SDS 
    10% (v/v) 2-mercaptoethanol  
 
1x Transfer Buffer:  25 mM Tris 
    190 mM glycine 
    20% (v/v) methanol 
 
Blocking solution for western blot: PBS 1x  
      0.1% (v/v) Tween 20 
      3% (w/v) dry milk 
 
Washing solution for western blot:  PBS 1x 
0.1% (v/v) Tween 20 
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Chapter 3 
Relevance of mRNA level in 
transient gene expression 
 
 
 
3.1 Introduction 
 
TGE in CHO cells is a well-established and scalable technique (1-4). However, the 
highest reported yields of secreted recombinant proteins in this host have been about 10-20 
mg/L after six days of production (1-3;5). The main cause(s) of low TGE yields in CHO 
cells have not been yet determined. However, the exposure of transfected CHO cells to 
hypothermic conditions (30-33 °C) (6;7) or histone deacetylase inhibitors (8-11) enhanced 
TGE yields significantly, meaning that improvements are possible for this host system. 
This chapter focuses on the role of pDNA amounts and mRNA level in TGE in CHO 
cells under standard transfection conditions at 37°C in order to begin to understand the 
molecular limitations of this host. First, it was observed that the pDNA copy number per 
cell did not correlate with the level of transgene mRNA. Instead, there appeared to be an 
upper limit to the amount of transgene mRNA produced by transfected cells. It was also 
observed that recombinant protein yield was strongly dependent on the mRNA level. 
Moreover, it was found that the amount of transgene mRNA decreased rapidly after 
reaching an optimum after transfection. Furthermore, protein expression from three 
different vectors was compared. In all cases, the transgene mRNA level correlated with the 
recombinant protein yield. Thus, methods to increase the transgene mRNA level appeared 
to be critical for enhancing TGE yields in CHO cells; therefore, the remaining chapters of 
this thesis describe experiments to address this problem in more detail.   
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3.2 Results 
 
 
3.2.1 DNA amount used for transfection  
 
The amount of DNA needed for optimal TGE yield was investigated by transfecting 
CHO DG44 cells with various amounts of a mix of three plasmids  (pXLGHEK-RhLC, 
pXLGHEK-RhHC, and pXLGHEK-EGFP at a mass ratio of 49:49:2).  The amount of PEI 
was also varied to keep the PEI:DNA ratio constant (4:1). Steady-state plasmid DNA and 
transgene mRNA levels were determined by qRT-PCR and the yield of IgG was measured 
by ELISA. The plasmid copy number per cell increased as the pDNA amount transfected 
increased (Figure 3.1).  
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Figure 3.1. Analysis of plasmid copy number after PEI-mediated transfection with increasing 
amounts of DNA. CHO DG44 cells were transfected with pXLGHEK-RhLC, pXLGHEK-RhHC, and 
pXLGHEK-EGFP at a 49:49:2 ratio (w/w/w) with increasing amounts of DNA as indicated. Four hours  
post-transfection the pDNA was extracted and quantified by qRT-PCR. Errors bars represent the 
standard deviation from two parallel experiments 
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The increasing amount of pDNA copy number per cell described above did not 
correlate with the steady-state level of transgene mRNA or the IgG yield in these 
transfections.  The maximal transgene mRNA level and IgG yield were reached when cells 
were transfected with 0.625 μg of DNA/million cells (Figure 3.2). The levels of transgene 
mRNA and IgG then decreased as the amount of pDNA per cell increased (Figure 3.2). 
The stability of pDNA over time was also an analyzed by qPCR. The maximum pDNA 
copy number per cell was found at 4 h post–transfection, then the pDNA copy number 
declined with time (Figure 3.3).  
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Figure 3.2. Effect of pDNA amount on transgene mRNA levels and recombinant protein 
production after PEI-mediated transfection. CHO DG44 cells were transfected with pXLGHEK-
RhLC, pXLGHEK-RhHC, and pXLGHEK-EGFP at a 49:49:2 ratio (w/w/w) with increasing amounts of 
DNA as indicated.  (A) At day 3 post-transfection total mRNA was extracted and quantified by qRT-
PCR. The delta-delta-Ct method was used to calculate the relative quantity of light chain mRNA 
using β-actin mRNA and mRNA from non-transfected cells for normalization. (B) At the same time 
IgG yield were measured by ELISA. Errors bars represent the standard deviation from two parallel 
experiments. 
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Figure 3.3. pDNA stability over time in transiently transfected CHO cells. CHO DG44 cells 
were transfected with pXLGHEK-RhLC, pXLGHEK-RhHC, and pXLGHEK-EGFP at a 49:49:2 ratio 
(w/w/w). At the times indicated, one million cells were harvested, and the pDNA was extracted and 
analyzed by qRT-PCR. A known amount of pDNA was used to create the standard curve. Error 
bars represent the standard deviation from two parallel experiments. 
 
 
 
3.2.2 Influence on TGE of vectors used for transfection  
 
To determine the variation in transient recombinant protein yield with different 
expression vectors, CHO DG44 cells were transfected with three different combinations of 
plasmids: (1) pEAK8-LH39, pEAK8-LH41, and pEGFP-N1 at a ratio of 29:69:2 (w/w/w); 
(2) pKML, pKMH, and pMYKpuro-EGFP at a ratio of 49:49:2 (w/w/w); and (3) 
pXLGHEK-RhLC, pXLGHEK-RhHC, and pXLGHEK-EGFP at a ratio of 49:49:2 (w/w/w). 
The ratios for the IgG light and heavy chain plasmids for the different vector sets were 
individually optimized previously for transient expression at 37 °C (4;12;13). Total GFP-
specific fluorescence was measured 3 days post-transfection, whereas IgG yields were 
quantified over a time period of 6 days after transfection. The highest GFP-specific 
fluorescence was observed after transfection with pMYKpuro-EGFP, whereas GFP 
expression was lower for transfections with pXLGHEK-EGFP and pEGFPN1 (Figure 3.4).  
Antibody expression over time also varied with the three sets of plasmids.  With  
pKML/pKMH and the pXLGHEK vectors, the IgG production peaked at 3 days post-
transfection, whereas using the pEAK8 vectors the maximal IgG level was found at day 5 
post-transfection (Figure 3.5).  
Chapter 3 – Relevance of mRNA level in transient gene expression 
 35
1 2 3
0
2
4
6
8
plasmid mix
R
FU
 (x
 1
03
)
 
Figure 3.4. Transient GFP-specific fluorescence using different vectors for transfection. 
Cells were transfected with (1) pEAK8-LH39, pEAK8-LH41, and pEGFP-N1 at a ratio of 29:69:2 
(w/w/w); (2) pKML, pKMH, and pMYKpuro-EGFP at a ratio of 49:49:2 (w/w/w); and (3) pXLGHEK-
RhLC, pXLGHEK-RhHC, and pXLGHEK-EGFP, at a ratio of 49:49:2 (w/w/w).  At day 3 post-
transfection the GFP-specific fluorescence was measured by fluorometry. Errors bars represent the 
standard deviation from three parallel experiments. 
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Figure 3.5. Transient IgG production over time after transfection with different vectors. Cells 
were transfected with (pXLG) pXLGHEK-RhLC, pXLGHEK-RhHC, and pXLGHEK-EGFP, at a ratio of 
49:49:2 (w/w/w); (pKML/H) pKML, pKMH, and pMYKpuro-EGFP at a ratio of 49:49:2 (w/w/w); and 
(pEAK8) pEAK8-LH39, pEAK8-LH41, and pEGFP-N1 at a ratio of 29:69:2 (w/w/w). At the times 
indicated the IgG concentration was quantified by ELISA. Errors bars represent the standard 
deviation from three parallel experiments. 
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3.2.3 Correlations between mRNA and protein levels 
 
To determine if the level of transgene mRNA correlates with recombinant protein 
yield by TGE, CHO cells were transfected with pXLGHEK-RhLC, pXLGHEK-RhHC, and 
pXLGHEK-EGFP at a ratio of 49:49:2 (w/w/w), and the IgG light chain mRNA level and 
IgG yield were determined at various times post-transfection. The highest steady-state 
level of IgG light chain mRNA was detected at 1 day post-transfection, whereas the 
highest concentration of IgG was found at day 3 post-transfection (Figure 3.6). 
In addition, the IgG light chain mRNA levels after transfection with different plasmids 
were quantified. The highest transgene mRNA level was found in cells transfected with 
pKML/pKMH followed by the pXLGHEK vectors and finally the pEAK8 vectors (Figure 
3.7).  
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Figure 3.6. IgG light chain mRNA levels and IgG production over time. CHO DG44 cells were 
transfected with pXLGHEK-RhLC, pXLGHEK-RhHC, and pXLGHEK-EGFP at a 49:49:2 ratio (w/w/w). 
At the times indicated, one million of cells were harvested. Total mRNA was extracted and light 
chain mRNA was quantified by qRT-PCR. The delta-delta-Ct method was used to calculate the 
relative quantity of light chain mRNA using β-actin mRNA and mRNA from non-transfected cells for 
normalization. IgG titres were measured by ELISA at the times indicated. Error bars represent the 
standard deviation from two parallel experiments. 
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Figure 3.7. Transient light chain mRNA levels following transfection with different vectors. 
Cells were transfected with (1) pEAK8-LH39, pEAK8-LH41, and pEGFP-N1 at a ratio of 29:69:2 
(w/w/w); (2) pKML, pKMH, and pMYKpuro-EGFP at a ratio of 29:69:2 (w/w/w); and (3) pXLGHEK-
RhLC, pXLGHEK-RhHC, and pXLGHEK-EGFP at a ratio of 49:49:2 (w/w/w). One day post-
transfection, one million cells were harvested, and total mRNA was extracted and light chain mRNA 
was quantified by qRT-PCR. The delta-delta-Ct method was used to calculate the relative quantity 
of light chain mRNA using the β-actin mRNA and mRNA from non-transfected cells for 
normalization. Error bars represent the standard deviation from three parallel experiments. 
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3.3    Discussion and conclusions 
 
Performing efficient PEI-mediated transfections to get high transient production yields 
is not an easy task. The plasmid DNA needs to enter the cells, reach the nucleus, and be 
transcribed. This work showed the importance of the transgene mRNA level in transient 
gene expression in CHO cells. The pDNA level in transfected cells, in fact, did not 
correlate with the levels of transgene mRNA level and recombinant protein. These levels 
were also dependent on the expression vector used for transfection. 
The amount of pDNA in cells after transfection was found to be in the range of 
10,000-40,000 copies per cell, depending on the amount of DNA used for transfection; 
these values were similar to those previously published for CaPi transfection in CHO cells 
(14). However, the pDNA level in cells decreased rapidly.  At day 2 post-transfection the 
amount of pDNA found in cells was decreased by 70% relative to the maximum level soon 
after transfection. Six days post-transfection, the pDNA quantity found was only 10% of 
the maximum level. Moreover, increasing the DNA amount used for transfection did not 
lead to higher protein yields. A similar phenomenon has previously been reported for PEI-
mediated transfections in CHO cells (1).  Here it was shown that the maximal amount of 
pDNA that can be delivered to cells to obtain good recombinant protein yields was 0.625 
μg/million cell (~15,000 copies/cell). Transfection with higher amounts of pDNA resulted 
in more pDNA uptake into cells but less transgene mRNA accumulation and recombinant 
protein production.  In the presence of 30,000 copies of pDNA per cell, the transgene 
mRNA level was 3 times lower than in presence of only 15,000 plasmid copies per cell. 
The lack of correlation between pDNA copy number and the transgene mRNA level may 
have been due to a limitation in transcription.  
Different expression vectors were compared in terms of recombinant protein 
production in CHO cells. Two plasmids, both carrying CMV promoters (4;13), gave the 
highest yields during the first three days of production, but from day 4 IgG levels 
decreased dramatically. In contrast, the pEAK8 plasmids (12), carrying the EF-1α 
promoter, showed a more constant production over six days after transfection. A possible 
explanation is that the viral promoters may be more prone to gene silencing that the 
promoter from a cellular housekeeping gene (15-17). No clear explanation was found for 
the decrease observed in recombinant IgG yields over time for the transfections with the 
vectors with a cytomegalovirus promoter. It is possible that proteases secreted by CHO 
cells degraded the recombinant IgG in the medium (18;19). 
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In conclusion, the data presented in this chapter demonstrated that the level of 
transgene mRNA appeared to be one of the main bottlenecks in transient gene expression 
in CHO cells. In the remaining chapters of this thesis, different strategies to increase the 
level and stability of transgene mRNA in transiently transfected CHO cells are described. 
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Chapter 4 
Mild hypothermia improves 
transient gene expression yields in 
CHO cells 
 
 
 
4.1 Introduction 
 
In standard bioprocesses, mammalian cells are cultivated at 37 °C, but it is well-
known that mild hypothermic conditions (27-34 °C) can induce an increase in protein 
production in some recombinant cell lines (1-6). More recently, hypothermic conditions 
have been shown to enhance TGE in CHO cells (7;8). The reason(s) for the low-
temperature enhancement of protein production from mammalian cells are not yet fully 
understood. Mild hypothermia causes an accumulation of cells in the G1 phase of the cell 
cycle and an increase in mRNA stability (9;10). Changes in cell metabolism and gene 
expression also occur at low temperatures (4;11;12). For example, the consumption of 
glucose and glutamine is reduced, leading to a lower production of cytotoxic metabolites 
such as lactate and ammonium; proteins able to stabilize mRNA such as cold-induced 
RNA binding protein (CIRBP) and Rbm3 are expressed; and the overall activity of the 
transcriptional-translational machinery is reduced (6;13).  
By performing TGE under mild hypothermic conditions, a substantial increase in 
volumetric productivity of recombinant anti-Rhesus D antibody was achieved in CHO 
cells. The increase in production correlated with accumulation of the transfected cells in 
G1, reduced cellular metabolism, increased steady-state levels of transgene mRNAs, 
increased cell size, and increased cell viability. The effect of hypothermia on TGE was 
time dependent, with the highest yields obtained when cells were transferred to low 
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temperature at 4 h after DNA addition. Part of the enhancement in antibody production 
resulted from the inclusion of the woodchuck hepatitis virus posttranscriptional element 
(WPRE) in the 3’ untranslated region of the transgene mRNA. Furthermore, it was shown 
that plasmid DNA stability was not enhanced by hypothermic conditions. Instead, 
increased transgene mRNA stability was found to be a key factor for the higher 
recombinant protein production. The results contribute to the understanding of low-
temperature enhancement of recombinant gene expression and demonstrate the feasibility 
of producing high quantities of secreted recombinant proteins in CHO cells by TGE. 
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4.2 Results 
 
 
4.2.1 Transient gene expression under hypothermic conditions 
 
To determine if low-temperature exposure enhanced TGE, CHO cells were transfected 
with a mixture of pXLGHEK-RhLC, pXLGHEK-RhHC, and pXLGHEK-EGFP at a mass ratio 
of 49:49:2 for the expression of recombinant antibody and GFP. At different times after 
DNA addition, the cultures were transferred to 31 °C or maintained at 37 °C as a control. 
The effect of the temperature shift on recombinant protein yield was most pronounced 
when the cells were transferred to 31 °C at 4 h after DNA addition (Figure 4.1). Transfer of 
the cultures to 31 °C after maintenance at 37 °C for more than 2 days had little effect on 
transient recombinant protein yield (Figure 4.1). For the culture shifted to 31 °C at 4 h 
post-transfection, the antibody yield was about 80 mg/L after 6 days. Similar results were 
obtained for transfections with the same three plasmids in a 20 L disposable reactor with a 
culture volumes of 10 L with a temperature shift to 31 °C at 4 h post-transfection (Figure 
4.2).  
The same three expression vectors were then used to determine the effect of 
temperatures other than 31 °C on TGE. Cells were transfected as described above and 
shifted to 29, 31, or 33 °C at 4 h post-transfection. At all three temperatures tested there 
was enhancement of antibody and GFP production relative to the control culture at 37 °C, 
with the highest yields of GFP (Figure 4.3A) and antibody (Figure 4.3B) at 31 and 33 °C, 
respectively. Overall, recombinant antibody yield was enhanced 12- to 18-fold and GFP 
yield was enhanced 2- to 4-fold by exposure of cells to mild hypothermia after transfection 
as compared to protein yields at 37 °C (Figure 4.3). 
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Figure 4.1. Effect of mild hypothermia on TGE. Cells were transfected with pXLGHEK-RhLC, 
pXLGHEK-RhHC, and pXLGHEK-EGFP at a 49:49:2 ratio (w/w/w). The transfected cells were shifted 
to 31 °C at the times indicated. The control transfection [C] was maintained at 37 °C. GFP-specific 
fluorescence (A) and antibody concentration in the medium (B) were measured at 6 days post-
transfection. The error bars represent the standard deviation from three parallel experiments. 
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Figure 4.2. Scale-up of TGE under hypothermic conditions. CHO DG44 cells were transfected 
with pXLGHEK-RhLC, pXLGHEK-RhHC, and pXLGHEK-GFP at a 49:49:2 ratio (w/w/w) at the 10 mL 
scale [●]  and the 10 L scale [▲].  (A) Recombinant IgG titres were determined at the times 
indicated.  (B) Cell growth [closed symbols] and viability [open symbols] were measured at the 
times indicated.  Error bars represent the standard deviation from three parallel experiments for the 
10 mL scale and from three samples of a single culture for the 10 L scale. 
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Figure 4.3. Enhancement of TGE at different temperatures. Cells were transfected with 
pXLGHEK-RhLC, pXLGHEK-RhHC, and pXLGHEK-EGFP at a 49:49:2 ratio (w/w/w) and either shifted 
to low temperature (29, 31, or 33 °C) at 4 h post-transfection or maintained at 37 °C (control) as 
indicated. GFP-specific fluorescence (A) and antibody concentration in the medium (B) were 
measured at 6 days post-transfection. The fold increase over the control is indicated above the bar 
representing the reporter protein yield at low temperature. The error bars represent the standard 
deviation from three parallel experiments. 
 
 
 
4.2.2 Vector influence on the low-temperature enhancement of TGE 
 
To determine if the low-temperature enhancement of TGE was dependent on the 
expression vector, cells were then transfected with three different combinations of 
plasmids: (1) pEAK8-LH39, pEAK8-LH41, and pEGFP-N1 at a ratio of 29:69:2 (w/w/w); 
(2) pKML, pKMH, and pMYKpuro-EGFP at a ratio of 49:49:2 (w/w/w); (3) pXLGHEK-
RhLC, pXLGHEK-RhHC, and pXLGHEK-EGFP at a ratio of 49:49:2 (w/w/w). The ratios for 
the IgG light and heavy chain plasmids for the different vector sets were individually 
optimized previously for transient expression at 37 °C (14-16). The cells were shifted to 31 
°C at 4 h post-transfection while the control transfections were maintained at 37 °C. For all 
three sets of vectors, enhanced antibody and GFP production at 31 °C relative to that of the 
control transfection was observed (Figure 4.4). Among the three GFP vectors, the GFP 
yield was clearly highest for pEGFP-N1 (Figure 4.4A), while the highest antibody yield 
was seen with pXLGHEK-RhLC and pXLGHEK-RhHC (Figure 4.4B). 
To further investigate the low-temperature enhancement of antibody production from 
cells transfected with pXLGHEK-RhHC and pXLGHEK-RhLC, the two vectors were 
modified to eliminate the post-transcriptional regulatory element WPRE to create 
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pXLGHEK-ΔWPRE-RhLC and pXLGHEK-ΔWPRE-RhHC. Cells were transfected with the 
two sets of light and heavy chain vectors at a 1:1 (w/w) ratio. At 4 h post-transfection the 
cultures were shifted to 31 °C, while the control transfections were maintained at 37 °C. 
The low-temperature enhancement of antibody yield was about 18-fold in the presence of 
the WPRE but only about 6-fold in its absence (Figure 4.5A). For each transfection, the 
steady-state levels of the IgG light and heavy chain mRNAs were determined by qRT-
PCR. Mild hypothermic conditions enhanced the levels of both the heavy and light chain 
mRNAs at 3 days post-transfection regardless of the presence or absence of the WPRE 
(data not shown). However, the light to heavy chain mRNA ratio at both 31 and 37 °C was 
higher in the presence of the WPRE than in its absence (Figure 4.5B). 
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Figure 4.4. Vector influence on low-temperature enhancement of TGE. Cells were transfected 
with (1) pEAK8-LH39, pEAK8-LH41, and pEGFP-N1 at a ratio of 29:69:2 (w/w/w); (2) pKML, 
pKMH, and pMYKpuro-EGFP at a ratio of 49:49:2 (w/w/w); and (3) pXLGHEK-RhLC, pXLGHEK-
RhHC, and pXLGHEK-EGFP at a ratio of 49:49:2 (w/w/w). The cells were either shifted to 31 °C at 4 
h post-transfection or maintained at 37 °C. GFP-specific fluorescence (A) and antibody 
concentration in the medium (B) were measured at 6 days post-transfection. The fold increase over 
the control is indicated above the bar representing the reporter protein yield at low temperature. 
The error bars represent the standard deviation from three parallel experiments. 
Chapter 4 – Mild hypothermia improves TGE yields in CHO cells 
 49
 WPRE ΔWPRE0
5
10
15
20
25
A
Ig
G
 y
ie
ld
 (f
ol
d 
in
cr
ea
se
)
WPRE ΔWPRE0
2
4
6
8
37°C
31°C
B
LC
/H
C
 m
R
N
A
 ra
tio
 
 
 
Figure 4.5. Effect of the WPRE on low-temperature enhancement of TGE. Cells were 
transfected with a 1:1 ratio (w/w) of pXLGHEK-RhLC and pXLGHEK-RhHC (designated WPRE) or 
pXLGHEK-∆WPRE-RhLC and pXLGHEK-∆WPRE-RhHC (designated ∆WPRE). (A) Antibody 
concentration in the medium was measured by ELISA at 6 days post-transfection. Antibody levels 
from temperature-shifted cultures were normalized to those of the control cultures at 37 °C. qRT-
PCR was used to determine the steady-state levels of the IgG heavy (HC) and light chain (LC) 
mRNAs at 3 days post-transfection. The levels of these two mRNAs were normalized to that of β-
actin mRNA with the delta Ct method. (B) The ratios of the relative levels of LC and HC mRNA for 
each transfection were determined. The error bars represent the standard deviation from three 
parallel experiments. 
 
 
 
4.2.3 Effect of hypothermia on GFP expression level over time 
 
To investigate other possible causes of the enhanced recombinant protein production 
under hypothermia, CHO cells were transfected with pXLGHEK-RhLC, pXLGHEK-RhHC, 
and pXLGHEK-EGFP at a 49:49:2 ratio (w/w/w), and at 4 h after transfection half of the 
samples were shifted to 31°C. The percentage of GFP-positive cells was determined by 
flow cytometry each day.  The percentage of GFP-positive cells was slightly higher for the 
cultures maintained at 37 °C as compared to those at 31 °C at most of the time points 
(Figure 4.6).  However, the percentage of GFP-positive cells remained stable for 6 days for 
the cultures at 31 °C whereas for those at 37°C this number decreased over time from a 
maximum at day 3 post-transfection (Figure 4.6).  This decline may have been caused by 
the decrease of cell viability at 37°C after day 3.  
Furthermore, in transfected cells maintained at 31°C, the GFP expression level 
increased over time (Figure 4.7).  For the cultures at 37 °C, the percentage of GFP-positive 
cells expressing high (++) levels of GFP decreased after day 3 post-transfection (Figure 
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4.8A). In contrast, for the cells at 31°C the percentage of GFP-positive cells with high (++) 
or very high (+++) levels of GFP expression increased over time (Figure 4.8B).  This 
phenomenon explains why the fluorescence measured at 31°C was higher than that 
measured at 37°C, even if the overall percentage of GFP-positive cells at 31°C was a lower 
than the one reported for the cells at 37°C. 
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Figure 4.6. Overall percentage of GFP-positive cells at 37 °C and 31 °C. Cells were transfected 
with pXLGHEK-RhLC, pXLGHEK-RhHC, and pXLGHEK-EGFP at a 49:49:2 ratio (w/w/w). At 4 h after 
transfection, cells were diluted and half of the samples were shifted to 31 °C. Every day after 
transfection a sample was recovered and analyzed by flow cytometry. The error bars represent the 
standard deviation from three parallel experiments. 
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Figure 4.7. Distribution of population of GFP positive cells at 37 °C and 31 °C. Cells were 
transfected with pXLGHEK-RhLC, pXLGHEK-RhHC, and pXLGHEK-EGFP at a 49:49:2 ratio (w/w/w). 
At 4 h after transfection, cells were diluted and half of the samples were shifted to 31 °C. Every day 
after transfection a sample was recovered and analyzed by flow cytometry (A).  The lower panels 
represent the analyzed data for cultures at 37 °C (B) and 31 °C (C). The error bars represent the 
standard deviation from two parallel experiments. 
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4.2.4 Effects of hypothermia on transgene mRNA and plasmid DNA 
stability  
 
Cells were transfected with pXLGHEK-RhLC, pXLGHEK-RhHC, and pXLGHEK-EGFP 
at a 49:49:2 ratio (w/w/w). The cultures were maintained at either 31 °C or 37 °C, and the 
steady-state level of IgG light chain mRNA was quantified daily. By 24 h post-transfection 
the cells kept at 31 °C contained more light chain mRNA than those at 37 °C (Figure 4.8). 
This difference became greater with time as the steady-state transgene mRNA level 
decreased with time in the cells at 37 °C (see Chapter 3) but not in those at 31 °C (Figure 
4.8). Since it has previously been shown that the level of the IgG light chain polypeptide is 
limiting for antibody assembly and production, only the steady-state level of this mRNA 
was determined (17;18).  
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Figure 4.8. Stability of IgG light chain mRNA over time. CHO DG44 cells were transfected with 
pXLGHEK-RhLC, pXLGHEK-RhHC, and pXLGHEK-EGFP at a 49:49:2 ratio (w/w/w). At 0, 1, 3, 5 and 7 
days post-transfection, one million of cells were harvested, and total mRNA was extracted and 
retro-transcribed into cDNA.  Samples were then analyzed by qRT-PCR. The delta-delta-Ct method 
was used to calculate the relative quantity of light chain mRNA using the β-actin mRNA and not 
transfected mRNA for normalization. Error bars represent the standard deviation from two parallel 
experiments.  
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One explanation for the increase of light chain mRNA stability under hypothermic 
conditions is that the temperature may have increased the stability of the plasmid DNA. To 
investigate this possibility, pDNA was extracted from transfected CHO DG44 cells 
maintained at either 31 °C or 37 °C at different times post-transfection and then quantified 
using qRT-PCR. For both cultures, the level of pDNA decreased dramatically during the 
first 48 h after transfection relative to the level at 4 h post-transfection (Figure 4.9). The 
pDNA level then remained the same until the end of the two cultures. The similarity of the 
results from cultures at 37 °C and 31 °C implied that the hypothermic conditions did not 
alter the stability of transfected pDNA.  
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Figure 4.9. Stability of transfected pDNA over time. CHO DG44 cells were transfected with 
pXLGHEK-RhLC, pXLGHEK-RhHC, and pXLGHEK-EGFP at a 49:49:2 ratio (w/w/w). At 0, 2, 4, 6 days 
after transfection one million of cells were harvested, and the pDNA was extracted with 
Phenol/Chlorophorm. Samples were than analyzed by qRT-PCR. A known amount of pDNA was 
used to create the standard curve. Error bars represent the standard deviation from two parallel 
experiments.  
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4.2.5 Effects of overexpression of cold shock proteins 
 
It is known that the cultivation of cells under hypothermic conditions induces the 
expression of several endogenous genes including those for the RNA binding proteins 
CIRBP and Rbm3 (13). These two proteins are thought to bind and stabilize mRNA under 
hypothermic stress (6). To determine if these proteins play a role in the low-temperature 
enhancement of TGE, CHO cells were co-transfected with a mixture of pXLGHEK-RhLC, 
pXLGHEK-RhHC, and pXLGHEK-EGFP, and either pMYK-CIRBP, pMYK-Rbm3, or 
pXLGHEK at a mass ratio of 44:44:2:10. The cells were maintained at 37°C throughout the 
experiment. The presence of the cold-shock proteins, however, had almost no effect on 
both GFP and antibody production under the conditions tested (Fig. 4.10). Similar results 
were observed when transfecting higher or lower amounts of the plasmids encoding the 
two cold-shock proteins (data not shown) or even after shifting cells to 31 °C. The 
overexpression of recombinant CIRBP and Rbm3 was confirmed by western blot analysis 
(Figure 4.11). The polyclonal antibody used for the detection of Rbm3 recognized also 
other unidentified cellular proteins (bands at ~40 KDa). Furthermore, from these results it 
appeared that the endogenous Rbm3 was expressed at low levels by CHO cells at 37 °C 
(Figure 4.11B, Control lane).   
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Figure 4.10. Effect of overexpression of cold-shock proteins. Cells were transfected with 
pXLGHEK-RhLC, pXLGHEK-RhHC, and pXLGHEK-EGFP, and either pMYK-CIRBP (CIRBP), pMYK-
Rbm3 (Rbm3), or pXLGHEK (Control) at a ratio of 44:44:2:10 (w/w/w/w) and maintained at 37°C. 
GFP-specific fluorescence (A) and antibody concentration in the medium (B) were measured 3 
days after transfection.  Error bars represent the standard deviation from three parallel 
experiments. 
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Figure 4.11. CIRBP (A) and Rbm3 (B) detection by Western Blot. CHO DG44 cells were 
transfected with pXLGHEK-RhLC, pXLGHEK-RhHC, and pXLGHEK-EGFP, and either pMYK-CIRBP 
(CIRBP), pMYK-Rbm3 (Rbm3) or herring sperm DNA (Control) at a mass ratio of 44:44:2:10. Three 
days after transfection five millions of cells were harvested, intracellular proteins were extracted, 
separated by SDS-PAGE, and immunoblotted with a monoclonal anti-CIRBP (A) or with a 
polyclonal anti-Rbm3 (B) antibody. Molecular weights [MW] are expressed in KDa. 
 
 
 
4.2.6 Characterization of hypothermic effects on transfected cells 
 
To better understand the mechanism of low temperature enhancement of TGE, CHO 
cells transfected with pXLGHEK-RhLC, pXLGHEK-RhHC, and pXLGHEK-EGFP were 
partially characterized by periodically analyzing biomass, cell viability, glucose and 
glutamine consumption, lactate and ammonium production, and cell size. The cells 
transferred to 31 °C at 4 h post-transfection were compared to those maintained at 37 °C. 
To compare the cell cycle phase distribution of cells maintained at 31 °C and 37 °C, CHO 
cells were transfected with herring sperm DNA and either shifted to 31 °C at 4 h post-
transfection or maintained at 37 °C. At different times the cells were stained with 
propidium iodide and analyzed by flow cytometry. By 3 days post-transfection, the cell 
cycle distribution at 31 °C was distinctly different from that at 37 °C, with a higher 
percentage of cells in the G1 phase for the 31 °C culture (Figure 4.12). By 6 days post-
transfection, almost all of the cells at 31 °C were in G1, but this was not the case for the 
culture maintained at 37 °C (Figure 4.12). 
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Surprisingly, the biomass accumulation for the two cultures was similar at times up to 
5 days post-transfection (Figure 4.13A). This could be explained in part by lower cell 
viability for the cultures at 37 °C (Figure 4.13B) and an increase in the average cell size at 
31 °C as compared to cells at 37 °C. For the cells at 31 °C, both the cell diameter (Figure 
4.13C) and the cell volume (Figure 4.13D) were greater as compared to cells at 37 °C. At 
31 °C, cell viability was >95% throughout the cultivation period, while cell viability at 37 
°C decreased to 40% by 6 days post-transfection (Figure 4.13B). In addition, the levels of 
glucose and glutamine consumption were lower at 31 °C than at 37 °C (Figure 4.13E, F), 
and the level of ammonium production was less at 31 °C than at 37 °C (Figure 4.13G). 
Lactate production was also lower at 31 °C than at 37 °C, but only up to 3 days post-
transfection (Figure 4.13H). 
 
 
 
Figure 4.12. Effects of mild hypothermia on cell cycle phase distribution. Cells were 
transfected with herring sperm DNA and either shifted to 31 °C at 4 h post-transfection (left panels) 
or maintained at 37 °C (right panels). Flow cytometry analysis was performed at the times 
indicated. The positions of cells in G1, S, and G2 plus M (M) are indicated in the upper left-hand 
panel. 
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Figure 4.13. Effects of mild hypothermia on cell growth and metabolism. Cells were transfected 
with pXLGHEK-RhLC, pXLGHEK-RhHC, and pXLGHEKEGFP at a ratio of 49:49:2 (w/w/w) and shifted 
to 31 °C at 4 h post-transfection (black ●) or maintained at 37 °C (grey ■). At the times indicated, 
biomass (A), cell viability (B), cell diameter (C), cell volume (D) glucose (E), glutamine (F), 
ammonium (G), and lactate (H) were measured as described in Materials and Methods. Each point 
represents the average of three independent experiments.  Error bars, when present, represent the 
standard deviation from two parallel experiments. 
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4.3    Discussion and conclusions 
 
This study demonstrated that a shift in cultivation temperature from 37 to 31 °C at 4 h 
after the transfection of CHO cells with PEI increased transient recombinant antibody yield 
up to 60-80 mg/L by 6 days post-transfection. This represents the highest level of transient 
antibody production in mammalian cells reported to date for a batch culture (19). These 
results have been extended by the demonstration that the low-temperature cultivation of 
transfected CHO cells yielded 50-60 mg/L of antibody within 10 days in orbitally shaken 
bottles of 10 or 20 L (14). The enhancement of TGE at 31 °C correlated with an 
accumulation of cells in the G1 phase of the cell cycle, reduced cellular metabolism, 
greater cell viability, increased cell size, shift of cell population towards higher 
recombinant protein production, and increased steady-state levels over time of transgene 
mRNA as compared to cells kept at 37 °C. The extent of the increase in protein yield was 
partly dependent on the expression vector used for transfection. More specifically, WPRE, 
which has a post-transcriptional effect on heterologous gene expression, was particularly 
effective in increasing transient recombinant protein yield at low temperatures.  
The enhancement of TGE by mild hypothermia was found to be time-dependent, with 
the greatest effect observed when cells were shifted to 31 °C 4 h after transfection. In 
contrast, little effect on protein yield was observed when the cells were shifted at 3 or more 
days after transfection. In a separate study on PEI-mediated transfection kinetics, it was 
shown for CHO cells in suspension that most of the DNA uptake occurs within 60 min of 
DNA-PEI addition (20). Thus, exposure of cells to low-temperature probably did not have 
a significant effect on DNA uptake since the protein yields following temperature shifts at 
the time of DNA addition or 4 h later were about the same.  
Furthermore, hypothermia did not have an influence on plasmid DNA stability.  The 
level of pDNA decreased dramatically during the first days after transfection both at 37 
and at 31 °C. However, the transgene mRNA level in cells under hypothermic conditions 
was not only higher than at 37 °C, as previously reported (2;6), but the steady-state level of 
the mRNA was more stable over time. Thus, the temperature shift may have affected one 
or more steps in the life cycle of the IgG light chain mRNA such as mRNA transcription, 
processing, transport, and degradation. 
Experiments addressing the importance of the WPRE indicated that post-
transcriptional events play a significant role in the low-temperature enhancement of TGE 
in CHO cells. This RNA element is known to have effects on polyadenylation, mRNA 
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transport, and translation (21). Here we showed that the ratio of the IgG light to heavy 
chain mRNA was at least 2-fold higher in the presence of the WPRE than in its absence at 
both 31 and 37 °C. In the absence of the WPRE, the light to heavy chain mRNA ratio was 
nearly 1:1 at 31 °C, while this ratio in the presence of the WPRE was about 5:1. It has 
previously been shown that the level of the light chain polypeptide is limiting for antibody 
assembly (17;18). Thus, the effect of the WPRE may be to increase the steady-state level 
of the light chain mRNA, resulting in higher light chain protein levels and higher antibody 
secretion.  
Interestingly, the overexpression in CHO cells of two cold-shock proteins (CIRBP and 
Rbm3) that were expected to stabilize mRNA under hypothermic conditions (13) failed to 
enhance transient recombinant protein production. Other studies have shown an increase in 
recombinant protein yield when either one of these proteins was stably expressed in a 
recombinant CHO-derived cell line (22;23).  
We also observed that mild hypothermia had an impact on the distribution of the GFP-
positive cell population; on the viability, size, and metabolism of cells; and on the cell 
cycle distribution. The accumulation of cells in the G1 phase of the cell cycle as the result 
of mild hypothermia has previously been described for recombinant CHO cell lines 
(3;11;24). Even though most of the cells shifted to 31 °C were no longer dividing by 3 
days post-transfection, the average cell volume increased about 2-fold relative to cells at 37 
°C. Thus, the biomass levels of the transfected cultures at 31 and 37 °C were 
approximately the same up to 5 days post-transfection. After this time point, cell viability 
at 37 °C decreased sharply. A similar increase in cell size and recombinant protein 
production was reported for transfected CHO cells blocked in the G2/M phase of the cell 
cycle following treatment with nocodazole (25). The difference in viability described here 
between the cultures at 31 and 37 °C was already evident by 3 days post-transfection, and 
this difference was increased by 6 days post-transfection. Cells at 31 °C maintained a high 
viability (>90%) for a longer time than at 37 °C. This may have been due to the reduced 
consumption of glucose and glutamine and the consequent reduction of lactate and 
ammonium production. A similar reduction in cellular metabolism has been observed for 
recombinant CHO cells lines maintained under mild hypothermic conditions (11;12). 
Subsequent transfections of CHO at scales up to 50 L demonstrated that the viability of 
CHO cells can remain above 90% for up to 11 days post-transfection at 31 °C (14). 
Transfected cells under hypothermic conditions had about the same percentage of GFP-
positive cells than the transfected cells cultured at 37°C. However, at 31°C the GFP-
positive population was shifted towards high-producing cells, leading to a higher GFP 
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level. These changes in cell growth and physiology due to mild hypothermia are likely to 
be important for enhancing transient recombinant protein yield, but additional studies are 
necessary to determine the precise pathways involved.  
Although the different mammalian expression vectors described in this study 
responded differently to low-temperature conditions, in all cases recombinant protein 
production was increased under mild hypothermia. Only the total protein yields and the 
extent of the enhancement of recombinant protein production varied. pEGFPN1 and 
pXLGHEK-RhLC/pXLGHEK-RhHC provided the highest absolute levels of GFP and 
antibody, respectively. The level of enhancement over the control transfection was 10-fold 
for pEGFP-N1 and 10-18-fold for pXLGHEK-RhLC/pXLGHEK-RhHC. Regardless of the 
fact that for all three of these plasmids the recombinant gene was under the control of the 
hCMV immediate early promoter, we cannot conclude that it is superior to the other 
promoters used in the study since the various plasmids included other elements which may 
have affected transgene expression at low temperatures. For example, the pXLGHEK-based 
plasmids included the adeno-associated virus inverted terminal repeats which have intrinsic 
promoter activity and the wild-type WPRE which encodes a truncated form of the 
woodchuck hepatitis virus X protein (26-28). Furthermore, the two reporter proteins also 
responded differently to hypothermic conditions which may signify differential low-
temperature effects on secreted and intracellular proteins. 
In conclusion, it was demonstrated that hypothermic conditions help to increase and 
stabilize transgene mRNA levels in transiently transfected CHO cells. Furthermore, the 
recombinant antibody levels observed here were the highest ever reported for transiently 
transfected CHO cells, and the present studies have been extended by performing 
transfections at scales up to 50 L in disposable containers agitated by orbital shaking (14). 
Thus, low-temperature TGE is a very promising technology for the rapid production of 
gram quantities of secreted recombinant proteins from CHO cells.  
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Chapter 5 
Valproic acid improves mRNA 
levels and transient gene 
expression yields in CHO cells 
 
 
 
5.1 Introduction 
 
Valproic acid (VPA or 2-propylpentanoic acid) is a carboxylic acid widely used in 
medicine for the treatment of epilepsy, depression, and other psychiatric disorders (1;2). 
Recently VPA has been identified as a histone deacetylase inhibitor (iHDAC) (1;3;4) and, 
like other iHDACs (i.e. sodium butyrate and Tricostatin A) (5-8), it has been used in cell 
cultures to increase recombinant protein yields (9). Its activity is not only selective to class 
I HDAC, but it has been reported to inhibit class II HDACs via proteasome-mediated 
degradation (10).  Like other iHDACs, VPA has been shown to alter the cell cycle 
distribution and block cell growth in vivo and in vitro (4;11;12). As already reported in 
Chapter 4, those effects may be positive for recombinant protein production using 
mammalian cells as the host system. In fact, under hypothermic conditions we observed a 
lower cell metabolism level and a block in the G1 phase of the cell cycle in addition to 
higher recombinant protein titers.  
In this chapter, the treatment of transiently transfected CHO DG44 cells with VPA is 
reported. A substantial increase in the volumetric productivity of GFP and IgG was 
achieved. With increasing VPA concentrations, cell viability and growth were negatively 
influenced but the IgG mRNA and protein levels increased with increasing VPA 
concentrations. As already reported in Chapter 4, increased transgene mRNA stability was 
found to be a key factor for enhanced transient recombinant protein production in this cell 
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line. Moreover, the enhancement on recombinant protein production in the presence of 
VPA was dependent on the expression vector used for transfection and on the expressed 
protein. A synergistic effect of VPA and hypothermia was also observed but only for low 
concentrations of VPA. The cause of the improved recombinant protein yield described 
here was mainly due to the iHDAC activity of VPA; however, changes in cell growth and 
metabolism also had an impact as shown with treatment of transfected cells with 
valpromide (VPD), a VPA analogue without iHDAC activity (1). Even if many questions 
about VPA activity in transiently transfected cells are still open, the results presented here 
contribute to the understanding of the mechanism of the enhancement of transient gene 
expression after VPA treatment. 
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5.2 Results 
 
 
5.2.1 Effect of VPA on transient protein production  
 
To determine if VPA-enhanced TGE, CHO cells were transfected with a plasmid mix 
containing pXLGHEK-RhLC, pXLGHEK-RhHC, and pXLGHEK-EGFP at a mass ratio of 
49:49:2. Four hours after transfection, cells were diluted according to the standard 
protocol, and VPA was added to different final concentrations from 0 - 5 mM. Cells were 
cultured at 37 °C and GFP and IgG expression were measured at various times after 
transfection.  
The presence of VPA significantly enhanced the expression of GFP and IgG. 
Antibody production was enhanced to the same level relative to the untreated control for 
all VPA concentrations tested (Figure 5.1). The transient IgG levels in the VPA-treated 
transfections were about 4-fold higher at day 3 post-transfection and almost 23-fold higher 
at day 6 post-transfection (Figure 5.1). Furthermore, IgG levels in the presence of VPA 
increased over-time and reached a plateau at day 7. This was different from the untreated 
control transfection in which the highest level of recombinant IgG was observed at day 3 
(Figure 5.1; see also Chapter 3, Section 3.2.2). GFP fluorescence was almost 2-fold higher 
in the presence of 1.25 mM VPA as compared to the untreated control (Figure 5.2). 
Increased GFP levels were also observed at high VPA amounts were added to the culture 
(Figure 5.2), but if VPA concentrations exceeded 2.5 mM the total fluorescence was only 
1.5-fold higher than the control. These results were confirmed by flow cytometry analyses: 
the percentage of GFP positive cells was slightly higher for the cultures treated with 1.25 
mM of VPA, but then decreased with increasing VPA concentration (Figure 5.3A. 
However, for the cells treated with VPA, the percentage of GFP-positive cells with high 
(++) or very high (+++) levels of GFP expression was higher than for the untreated control 
transfection (Figures 5.3B and 5.3C). This phenomenon explains why the total 
fluorescence measured in the presence of VPA was higher than that measured for the 
control, even if the overall percentage of GFP-positive cells treated with VPA was almost 
the same in all the transfections. 
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Figure 5.1. Effect VPA treatment on transient IgG production. CHO DG44 cells were 
transfected with pXLGHEK-RhLC, pXLGHEK-RhHC, and pXLGHEK-GFP at a 49:49:2 ratio (w/w/w). 
Four hours after transfection, VPA was added to different concentrations. The concentration of 
recombinant IgG was measured by ELISA at the times indicated. Error bars represent the standard 
deviation from two parallel experiments. 
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Figure 5.2. Effect of VPA on transient GFP expression. CHO DG44 cells were transfected with 
pXLGHEK-RhLC, pXLGHEK-RhHC, and pXLGHEK-GFP at a 49:49:2 ratio (w/w/w). Four hours after 
transfection, VPA was added to different concentrations. GFP expression was measured at the 
times indicated.  Error bars represent the standard deviation from two parallel experiments. 
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Figure 5.3. Effect of VPA on transient GFP expression. CHO DG44 cells were transfected with 
pXLGHEK-RhLC, pXLGHEK-RhHC, and pXLGHEK-GFP at a 49:49:2 ratio (w/w/w). Four hours after 
transfection, VPA at different concentrations was added to different concentrations.  The cultures 
were sampled at day 3 post-transfection. The percentage (A) and distribution of GFP-positive cells 
(B,C) were determined by flow cytometry at each VPA concentration. Error bars represent the 
standard deviation from two parallel experiments. 
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5.2.2 Growth and viability of cells treated with VPA 
 
CHO cells were transfected as described in Section 5.2.1 and 4 hours after transfection 
different concentrations of VPA were added. At various times after transfection, the cell 
density and viability were determined by manual cell counting and the biomass was 
measured using mini-PCV tubes. VPA significantly influenced the cell density (Figure 
5.4A). Cultures treated with VPA at a concentration of 2.5 mM or higher did not reach a 
cell concentration greater than 4 x 106 cells/mL whereas the cell density of the untreated 
culture reached 7 x 106 cells/mL (Figure 5.4A). The impact of VPA on cell viability was 
even more pronounced. The viability decreased dramatically with increasing VPA 
concentration (Figure 5.4B). At day 7 post-transfection, all the cells in the presence of 3.75 
and 5 mM VPA were dead. It was observed by light microscopy that cells treated with 
VPA were smaller than the untreated control cells. This phenomenon could correlate to the 
huge influence that VPA had on total biomass. The biomass of cultures treated with VPA 
was almost 3.5-fold lower that of the untreated control transfection (Figure 5.4C).  
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Figure 5.4A.  Effect of VPA on cell growth. CHO DG44 cells were transfected with pXLGHEK-
RhLC, pXLGHEK-RhHC, and pXLGHEK-GFP at a 49:49:2 ratio (w/w/w). Four hours after transfection, 
VPA was added to different concentrations.  Cell growth was measured at various times after 
transfection.  Error bars represent the standard deviation from two parallel experiments. 
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Figure 5.4B and 5.4C.  Effect of VPA on viability and biomass. CHO DG44 cells were 
transfected with pXLGHEK-RhLC, pXLGHEK-RhHC, and pXLGHEK-GFP at a 49:49:2 ratio (w/w/w). 
Four hours after transfection, VPA was added to different concentrations.  Viability (B), and PCV 
(C) were measured at various times after transfection.  Error bars represent the standard deviation 
from two parallel experiments. 
 
 
 
5.2.3 Effect of VPA on mRNA level and stability 
 
To better characterize the intracellular effects of VPA on CHO cells, the steady-state 
level of IgG light chain mRNA was quantified 3 days after transfection. CHO cells were 
transfected with pXLGHEK-RhLC, pXLGHEK-RhHC, and pXLGHEK-EGFP at a 49:49:2 
ratio (w/w/w) and 4 h after transfection VPA was added to various concentrations. The IgG 
light chain mRNA level, as determined by qRT-PCR, increased as the VPA concentration 
increased and was 13-fold higher than in the untreated control in the presence of 5 mM of 
VPA (Figure 5.5A). However, the recombinant IgG level did not follow the same pattern 
as the IgG light chain mRNA level. The highest levels of IgG were reached in the presence 
of 2.5-3.75 mM VPA and did not increase with further addition of VPA (Figure 5.5B). The 
plateau of IgG production with increasing concentrations of VPA may have been due to the 
low viability associated with the VPA treatment.   
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Figure 5.5. Effect of VPA on the steady-state IgG light chain mRNA level and on rhIgG 
production. CHO DG44 cells were transfected with pXLGHEK-RhLC, pXLGHEK-RhHC, and 
pXLGHEK-GFP at a 49:49:2 ratio (w/w/w). Four hours after transfection, VPA was added to different 
concentrations.  mRNA (A) and IgG levels (B) were measured at day 3 post-transfection. The delta-
delta-Ct method was used to calculate the relative quantity of light chain mRNA using the β-actin 
mRNA and mRNA from non-transfected cells for normalization. Error bars represent the standard 
deviation from two parallel experiments. 
 
 
 
To further characterize the effect of VPA on transfected cells, the steady-state IgG 
light chain mRNA level was measured in the presence of 3.75 mM VPA at different times 
after transfection. Cells were transfected as described in the previous experiment, and the 
relative steady-state level of IgG light chain mRNA was determined by qRT-PCR.  Levels 
of mRNA were significantly higher in the presence of VPA as compared to the untreated 
control culture, and this difference increased with time (Figure 5.6A). Transient 
recombinant IgG production reflected the steady-state IgG light chain mRNA level (Figure 
5.6B). Similar results were observed for the quantification of the IgG heavy chain mRNA 
(data not shown). 
 
 
Chapter 5 – VPA improves mRNA levels and TGE yields in CHO cells 
 71
0 2 4 6
0
10
20
30
40
Control
VPA A
Time after transfection [days]
N
or
m
al
iz
ed
 le
ve
ls
 o
f L
C
 m
R
N
A
 (x
10
3 )
0 2 4 6
0
10
20
30
40
50
Control
VPA B
Time after transfection [days]
Ig
G
 [m
g/
L]
 
 
Figure 5.6. Effect of VPA on the steady-state IgG light chain mRNA level and on IgG 
production. CHO DG44 cells were transfected with pXLGHEK-RhLC, pXLGHEK-RhHC, and 
pXLGHEK-GFP at a 49:49:2 ratio (w/w/w). Four hours after transfection, VPA was added to 3.75 
mM.  The steady-state IgG light chain mRNA level (A) and recombinant IgG (B) were measured at 
the times indicated. The delta-delta-Ct method was used to calculate the relative quantity of light 
chain mRNA using the β-actin mRNA and mRNA from non-transfected cells for normalization. Error 
bars represent the standard deviation from two independent experiments. 
 
 
 
5.2.4 pDNA stability after VPA treatment 
 
The IgG light chain mRNA levels following transfection in the presence of VPA may 
have enhanced due to higher pDNA stability. To test this possibility, CHO cells were 
transfected with pXLGHEK-RhLC, pXLGHEK-RhHC, and pXLGHEK-EGFP at a ratio of 
49:49:2 (w/w/w), and at 4 h after transfection, 3.75 mM VPA was added. pDNA was 
extracted at various times after transfection. As already reported for hypothermic 
conditions (see Chapter 4), the steady-state level of pDNA was decreased by about 50% 
within 24 h post-transfection and continued to decrease over time in both the VPA-treated 
and the untreated culture as determined by qRT-PCR (Figure 5.7). Thus, VPA did not help 
to stabilize pDNA in cells after transfection. 
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Figure 5.7. Effect of VPA on pDNA stability in CHO cells. CHO DG44 cells were transfected 
with pXLGHEK-RhLC, pXLGHEK-RhHC, and pXLGHEK-EGFP at a 49:49:2 ratio (w/w/w). Four hours 
after transfection VPA was added to 3.75 mM. Transfected cells not treated with VPA were used as 
the control. At the times indicated, one million cells were harvested, and the pDNA was extracted. 
Samples were than analyzed by qRT-PCR. A known amount of pDNA was used to create the 
standard curve. Error bars represent the standard deviation from two separate experiments 
 
 
 
5.2.5 Influence of expression vector on the VPA enhancement of TGE 
 
CHO cells were transfected with three different combinations of plasmids: (1) 
pEAK8-LH39, pEAK8-LH41, and pEGFP-N1 at a ratio of 29:69:2 (w/w/w); (2) pKML, 
pKMH, and pMYKpuro-EGFP at a ratio of 49:49:2 (w/w/w); (3) pXLGHEK-RhLC, 
pXLGHEK-RhHC, and pXLGHEK-EGFP at a ratio of 49:49:2 (w/w/w). The ratios for the 
IgG light and heavy chain plasmids for the different vector sets were individually 
optimized previously for transient expression at 37 °C (13-15). The cells were treated with 
3.75 mM VPA at 4 h post-transfection, and at 3 days post-transfection IgG titers were 
quantified by ELISA. The greatest effect on IgG yield- almost 8-fold increase over the 
untreated control- was observed using the pXLGHEK vectors (Figure 5.8).  By comparison, 
VPA increased IgG production 3-fold following transfection with pKML and pKMH, 
while IgG production was decreased 0.5-fold when using the pEAK8 vectors (Figure 5.8).  
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Figure 5.8. Vector influence on VPA enhancement of TGE. Cells were transfected with (1) 
pEAK8-LH39, pEAK8-LH41, and pEGFP-N1 at a ratio of 29:69:2 (w/w/w); (2) pKML, pKMH, and 
pMYKpuro-EGFP at a ratio of 29:69:2 (w/w/w); and (3) pXLGHEK-RhLC, pXLGHEK-RhHC, and 
pXLGHEK-EGFP at a ratio of 49:49:2 (w/w/w). The cells were either treated with 3.75 mM VPA at 4 
h post-transfection (VPA) or not treated (control). The recombinant IgG concentration in the 
medium was measured at 3 days post-transfection. The fold increase over the control is indicated 
above the bar representing the reporter protein yield after treatment with VPA. The error bars 
represent the standard deviation from two independent experiments. 
 
 
 
5.2.6 Use of VPA under hypothermic conditions 
 
To determine if VPA treatment in combination with a hypothermic shift could have a 
synergistic effect on TGE, CHO cells were transfected with pXLGHEK-RhLC, pXLGHEK-
RhHC, and pXLGHEK-EGFP at a 49:49:2 ratio (w/w/w). Four hours after transfection VPA 
was added to different concentrations and the cultures were shifted to 31 °C. In contrast to 
the enhancement of IgG production in the presence of VPA at 37 °C (see Figures 5.1 and 
5.5B), at 31 °C the addition of 1.25 mM VPA only increased IgG yields about 30% relative 
to the untreated control transfection at 31 °C (Figure 5.9).  At higher VPA concentrations a 
negative impact on recombinant protein production was observed (Figure 5.9). By 
analyzing the distribution of GFP-positive cells after transfection, it was found that the 
level of high-producing GFP-positive cells (+++) was 2-fold higher in the presence of VPA 
than in its absence at 31 °C (Figure 5.10).  Finally, the steady-state IgG light chain mRNA 
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level in the presence of 1.25 mM VPA with incubation at 31 °C did not differ from the 
control transfection as determined by qRT-PCR (Figure 5.11). 
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Figure 5.9. Effect of VPA on IgG production under hypothermic conditions. CHO DG44 cells 
were transfected with pXLGHEK-RhLC, pXLGHEK-RhHC, and pXLGHEK-GFP at a 49:49:2 ratio 
(w/w/w). Four hours after transfection, VPA was added to 1.25 mM and the cells were shifted to 31 
°C. IgG titers were measured at day 6 post-transfection. Error bars represent the standard 
deviation from two independent experiments. 
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Figure 5.10. Effect of VPA and hypothermic treatment on GFP expression. CHO DG44 cells 
were transfected with pXLGHEK-RhLC, pXLGHEK-RhHC, and pXLGHEK-GFP at a 49:49:2 ratio 
(w/w/w). Four hours after transfection, 1.25 mM VPA was added and cells were shifted to 31 °C.  
The control culture was not treated with VPA but was only cultivated at 31 °C after transfection.  At 
day 3 post-transfection the cells were analyzed by flow cytometry. Error bars represent the 
standard deviation from two independent experiments.  The histograms from the flow cytometer (A) 
and the distribution of GFP-positive cells into different arbitrary categories (B) are shown. 
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Figure 5.11. Effect of VPA on the steady-state IgG light chain mRNA level under 
hypothermic conditions. CHO DG44 cells were transfected with pXLGHEK-RhLC, pXLGHEK-RhHC, 
and pXLGHEK-GFP at a 49:49:2 ratio (w/w/w). Four hours after transfection, VPA was added to 1.25 
mM and the cells were shifted to 31 °C.  Steady-state IgG light chain mRNA levels were measured 
at day 3 post-transfection. The delta-delta-Ct method was used to calculate the relative quantity of 
light chain mRNA using the beta-actin mRNA and the mRNA from non-transfected cells for 
normalization. Error bars represent the standard deviation from two independent experiments 
 
 
 
5.2.7 The impact of VPA’s iHDAC activity on TGE 
 
To better understand the possible influence of the iHDAC activity of VPA, transiently 
transfected CHO cells were treated either with VPA or with VDP, an analogue of VPA that 
does not inhibit HDAC activity (Figure 5.12) (1).  
 
 
  
 
 
 
 
 
 
 
 
Figure 5.12. Schematic diagrams of the chemical structures of VPD (A) and VPA (B). 
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CHO cells were transfected with pXLGHEK-RhLC, pXLGHEK-RhHC, and pXLGHEK-
EGFP at a 49:49:2 ratio (w/w/w). Four hours after transfection, VPA or VPD was added to 
various concentrations. The recombinant IgG yield of each transfection was determined at 
6 days post-transfection. Although both VPA and VPD had positive effects on recombinant 
IgG yield, but the highest titers achieved with VPD were only half of those reached with 
VPA (Figure 5.13). 
The effect of VPD on TGE was also analyzed with other IgG expression vector 
combinations. CHO cells were transfected with: (1) pEAK8-LH39, pEAK8-LH41, and 
pEGFP-N1 at a ratio of 29:69:2 (w/w/w); (2) pKML, pKMH, and pMYKpuro-EGFP at a 
ratio of 49:49:2 (w/w/w); and (3) pXLGHEK-RhLC, pXLGHEK-RhHC, and pXLGHEK-EGFP 
at a ratio of 49:49:2 (w/w/w). Four hours after transfection, 2.5 mM VPA or VPD were 
added to the cultures.  The recombinant IgG yields were quantified 3 days post-
transfection. The IgG yields for each set of transfections varied (Figure 5.14).  With the set 
of pXLGHEK vectors, VPA had a greater effect than VPD on recombinant IgG production. 
In contrast, IgG production was about the same from pKML and pKMH and from the 
pEAK8 vector set in the presence of either VPA or VPD (Figure 5.14). 
 
0.00 1.25 2.50
0
10
20
30
40
50
VPA
VPD
VPA or VPD [mM]
Ig
G
 [m
g/
L]
 
 
Figure 5.13. Effect of VPA and VPD on transient IgG production. CHO DG44 cells were 
transfected with pXLGHEK-RhLC, pXLGHEK-RhHC, and pXLGHEK-GFP at a 49:49:2 ratio (w/w/w). 
Four hours after transfection, VPA or VPD was added to various concentrations. Recombinant IgG 
titers were measured by ELISA at day 6 post-transfection. Error bars represent the standard 
deviation from two independent experiments. 
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Figure 5.14. Effect of VPA and VPD on transient rhIgG production from different vectors. 
CHO DG44 cells were transfected with (1) pEAK8-LH39, pEAK8-LH41, and pEGFP-N1 at a ratio of 
29:69:2 (w/w/w); (2) pKML, pKMH, and pMYKpuro-EGFP at a ratio of 29:69:2 (w/w/w); and (3) 
pXLGHEK-RhLC, pXLGHEK-RhHC, and pXLGHEK-EGFP at a ratio of 49:49:2 (w/w/w). The cells were 
treated with 2.5 mM VPA or VPD at 4 h post-transfection. Recombinant IgG concentration in the 
medium was measured at 3 days post-transfection by ELISA. The error bars represent the 
standard deviation from two independent experiments. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter 5 – VPA improves mRNA levels and TGE yields in CHO cells 
 78 
5.3    Discussion and conclusions 
 
The data reported here provide a better understanding of the effects of VPA on TGE in 
CHO cells. VPA increased recombinant protein yields up to 20-fold at 37 °C. The 
enhancement was dependent on the VPA concentration, the recombinant protein being 
expressed, and the expression vector itself. The increased protein production was related to 
the increase in the steady-state level and the stability of the transgene mRNA, at least for 
the IgG light and heavy chain mRNAs. This was due in part to the ability of VPA to inhibit 
HDAC activity (3;4). However, it was also observed that VPD, a VPA analogue without 
iHDAC activity, also enhanced transient recombinant protein production. Thus, the ability 
of VPA and VPD to arrest cell growth was also important for the enhancement of TGE.   
With VPA treatment, the transient production of both reporter proteins, GFP and IgG, 
increased. Cells treated with VPA had a 4-fold increase of IgG production at day 3 post-
transfection. Moreover, the IgG yields from cultures treated with VPA increased up to day 
7 post-transfection as did the IgG light chain mRNA level. Here it was shown that steady-
state transgene mRNA levels were higher in the presence of VPA than in its absence. 
Similar results on transgene mRNA levels have previously been reported for the effects of 
sodium butyrate, another histone deacetylase inhibitor (5). Furthermore, in the presence of 
VPA, the transgene mRNA level increased over time and in a dose-dependent manner. In 
contrast, the level of pDNA was not stabilized after treatment with VPA. The pDNA copy 
number per cell decreased dramatically from the first hours after transfection either in the 
presence or in absence of VPA.  
The enhancement of the recombinant IgG yield was not dose-dependent whereas that 
of GFP was. Since GFP is an intracellular protein, its expression and accumulation is 
strongly correlated to cell viability. Samples treated with high concentrations of VPA (> 
2.5 mM) had low cell viability, confirming what has already been reported in literature 
(1;11;12). However, GFP expression in the presence of VPA was always higher than in the 
untreated control. After VPA treatment, a greater percentage of the GFP-positive cells 
were present as high-producing cells, leading to a higher total fluorescence. 
It has been reported that VPA has an impact on cell growth (1;11;12).  Recently, VPA 
treatment of HeLa cells was shown to up-regulate p21/WAF-1, a cyclin-dependent kinase 
inhibitor, and blocked the cell cycle in the G1/G0 phase (16). Here it was shown that the 
cell growth arrest induced by VPA was dose-dependent. Moreover, cell morphology was 
altered in the presence of VPA. Cell size was reduced as the concentration of VPA 
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increased, leading to a lower biomass accumulation in the transfected cultures. By treating 
transfected cells with VPD, an analogue of VPA that does not inhibit HDACs (1), it was 
shown that the iHDAC activity of VPA was not the only factor in the enhancement of 
TGE. Like VPA, VPD also arrested CHO growth and reduced total biomass, but it only 
enhanced transient IgG production 4-10-fold as compared to 8-20-fold for VPA. 
Lowered cell metabolism, increased steady-state transgene mRNA levels, and 
increased recombinant protein production are phenomena that have also been observed in 
transfected CHO DG44 cells cultured under hypothermic conditions (17;18)(see also 
Chapter 4). For this reason, the effect of VPA at 31 °C was investigated. The combination 
of hypothermia and VPA led to a increase in transient recombinant protein yield compared 
to either treatment alone but only when low VPA concentrations were used. This 
improvement in yield appeared to be related to an increase in the number of high-
producing cells in the transfected population. However, the synergistic effect of VPA 
combined with low temperature was not accompanied by an additional increase in the 
steady-state level of transgene mRNA as compared to the cells maintained at 31 °C in the 
absence of VPA.   
Until now, there has been no report concerning the effect of VPA on transient protein 
production with different expression vectors. Here it was shown that the enhancement of 
protein yield in the presence of VPA was vector-dependent. Three days post-tramsfection, 
the enhancement of transient gene expression from pXLGHEK and pKML/pKMH vectors 
was up to 8-fold following VPA treatment, whereas VPA had a negative effect on 
transgene expression when using the EF-1α promoter. The vectors that supported the 
greatest enhancement of TGE in the presence of VPA (pXLGHEK and pKML/pKMH) were 
the ones in which the transgene was under the control of the human or mouse CMV 
promoter/enhancer. It has been reported that viral promoters are prone to epigenetic 
silencing (5;19;20). Thus a possible explanation for the differential effects of VPA on the 
various promoters tested here is that the mCMV and the hCMV were more subject to 
negative epigenetic effects than was the cellular EF-1α promoter. However, other 
hypotheses could explain the different behaviour of the three plasmids. For example, each 
vector was different with regard to other sequence elements besides the promoter that may 
have been prone to epigenetic silencing (21;22). The negative effect of VPA treatment on 
the pEAK8 vectors appeared to be linked to cell growth arrest since VPD treatment also 
had a negative effect on recombinant protein production when these vectors were used. 
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In conclusion, this study demonstrated that VPA increases recombinant protein 
production in transiently transfected CHO cells. Furthermore, it was shown that the steady-
state level and stability of the transgene mRNA were increased in the presence of VPA. 
Due to its low cost and ease of use, the treatment of transfected cells with VPA is a 
promising strategy to improve TGE at small or large scale. However, further studies will 
be necessary to better understand the mechanism of VPA on transient recombinant protein 
productivity.   
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Chapter 6 
Overexpression of selected 
transcription factors and growth 
factors enhances TGE yields in 
CHO cells 
 
 
 
6.1 Introduction 
 
Gene expression in mammalian cells is a complex phenomenon regulated by specific 
transcription factors. To accomplish their function these factors are able to bind specific 
DNA sequences within the enhancer and/or promoter of a gene and to recruit 
transcriptional activators and the RNA Polymerase II holoenzyme (1;2). The expression of 
the transcription factors themselves or their activation from an inactive form can be 
induced by external stimuli such as exposure to growth factors that function through 
phosphorylation cascades (1). The human cytomegalovirus early promoter/enhancer has 
several binding sites for transcription factors, particularly NF-kB, c-jun, c-fos, CREB, 
Elk1, and Sp1 (3-7). Therefore, the transcription of a transgene under its control may be 
expected to be stimulated by overexpression of these proteins. 
In this chapter two different approaches aimed at increasing TGE yields following 
transfection with plasmids containing the hCMV promoter/enhancer are reported. The first 
strategy involved the overexpression of different transcription factors together with the 
reporter gene(s) in CHO cells. The second strategy was aimed at increasing TGE yields 
through external stimulation with growth factors (8-11). This work leads to possible 
approaches to increase transgene mRNA levels and thus recombinant protein expression in 
CHO cells. 
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6.2 Results 
 
 
6.2.1 Effect of overexpression of transcription factors on TGE 
 
CHO DG44 cells were transfected with a mixture containing 30% of the transcription 
factor cDNA cloned in pXLGHEK and 70% of pXLGHEK-RhLC, pXLGHEK-RhHC, and 
pXLGHEK-EGFP [49:49:2 (w/w/w)]. IgG and GFP yields were analyzed at day 3 post-
transfection. For both proteins a 2- to 3-fold increase in yield was observed when the 
transcription factors c-jun, c-fos, NF-kB, or Sp1 were overexpressed (Figure 6.1). In 
contrast, overexpression of CREB and Elk1 did not contribute to the enhancement of 
recombinant protein expression.  
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Figure 6.1. Effect of overexpression of transcription factors on TGE. Cells were transfected 
with a mixture containing 30% of pXLGHEK-transcription factor and 70% of pXLGHEK-RhLC, 
pXLGHEK-RhHC, and pXLGHEK-EGFP (mass ratio 49:49:2). For the control transfections, pXLGHEK 
replaced pXLGHEK-transcription factor. GFP-specific fluorescence (A) and antibody concentration in 
the medium (B) were measured at 3 days post-transfection. The fold increase over the control is 
indicated above the bar representing each overexpressed transcription factor. The error bars 
represent the standard deviation from two parallel experiments. 
 
Chapter 6 – Overexpression of transcription and growth factors enhances TGE in CHO cells 
 85
For each transfection described above, the IgG light chain mRNA level was 
determined by qRT-PCR (12;13).  The relative level of IgG light chain mRNA was 2.5-
fold higher in the presence of NF-kB and 2-fold higher when c-fos, c-jun or Sp1 were 
overexpressed (Figure 6.2). The overexpression of CREB led to a relative decrease in the 
amount of the light chain mRNA, whereas the presence of Elk1 increased the light chain 
mRNA level 1.5-fold relative to the control. 
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Figure 6.2. Effect of transcription factor overexpression on relative IgG light chain mRNA 
accumulation. Cells were transfected with a mixture containing 30% of pXLGHEK-transcription 
factor and 70% of pXLGHEK-RhLC, pXLGHEK-RhHC, and pXLGHEK-EGFP (mass ratio of 49:49:2). 
Control transfections were performed by replacing pXLGHEK –transcription factor with pXLGHEK.  At 
day 3 post-transfection, one million cells were harvested, and total mRNA was extracted and 
retrotranscribed into cDNA.  Samples were then analyzed by qRT-PCR. The delta-delta-Ct method 
was used to calculate the relative quantity of IgG light chain mRNA using β-actin mRNA and mRNA 
from non-transfected cells for normalization. Error bars represent the standard deviation from two 
parallel experiments. 
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To determine the optimal amount of transcription factor plasmid per transfection, 
CHO DG44 cells were transfected as described above except that pXLGHEK-transcription 
factor was varied from 0 to 40%. For the c-fos, c-jun, NF-kB, and Sp1 vectors, the 
maximum effect on reporter protein yield was observed when these plasmids represented 
20-30% of the transfected DNA (Table 6.1). The presence of CREB and Elk1 did not 
enhance transient recombinant protein yields at any conditions tested (Table 6.1). 
Moreover combinations of different transcription factor vectors were tested but there were 
no differences compared to the use of single vectors in terms of IgG yields (data not 
shown). 
 
Table 6.1. Optimal amounts of transcription factor vectors for TGE. 
Transcription Factor Optimal amount of plasmid DNA  
c-fos 30 % 
c-jun 20 % 
NF-kB 30 % 
Sp1 30 % 
Elk1 0 %  
CREB 0 % 
 
 
 
6.2.2 Effect of VPA in combination with exogenous transcription factors 
on TGE yields 
 
The influence of VPA on TGE yields in CHO cells has been observed (see Chapter 5). 
CHO cells were transfected with a mixture of plasmids containing 30% pXLGHEK-
transcription factor and a 1:1 (w/w) mix of pXLGHEK-RhHC and pXLGHEK-RhLC (70% of 
the total DNA). At 4 h post-transfection, VPA was added to a final concentration of 2.5 
mM (Chapter 5). Antibody production was quantified 3 and 6 days post-transfection. 
Overall, the recombinant IgG yields were higher with VPA (Figure 6.3), but the strongest 
effect was noticed six days post-transfection (Figure 6.3B). The highest IgG yields were 
observed when the cells treated with VPA or NaBut had been co-transfected with vectors 
for c-fos, c-jun, or NF-kB overexpression (Figure 6.3B).    
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Figure 6.3. Effect of VPA and overexpression of transcription factors on transient IgG 
production. Cells were transfected with a mixture containing 30% of pXLGHEK-transcription factor 
and 70% of pXLGHEK-RhLC and pXLGHEK-RhHC (mass ratio of 50:50). The control transfections 
were performed by replacing a transcription factor vector with pXLGHEK.  At 4 h post-transfection 
VPA to 2.5 mM was added to the culture. At 3 (A) and 6 (B) days post-transfection, the 
recombinant IgG concentration was determined by ELISA. Error bars represent the standard 
deviation from three parallel experiments. 
 
 
 
6.2.3 TGE yields in stable cells overexpressing c-fos 
 
Pools of CHO cells stably overexpressing c-fos were selected in the presence of 
puromycin after co-transfection of pMYKEF1-puro-EGFP and pXLGHEK-c-fos. Control 
cell lines were selected after transfection with pMYKEF1-puro-EGFP alone.  Pools of 
puromycin-resistant cells (± c-fos overexpression) were transfected with pXLGHEK-RhLC 
and pXLGHEK-RhHC (mass ratio of 50:50) and IgG yields were quantified 6 days post-
transfection. In the presence of c-fos the antibody production was 1.5-fold higher than in 
the control cell pool (Figure 6.4A). Immunoblot with a polyclonal antibody against c-fos 
confirmed its overexpresssion in the pool of cells transfected with pXLGHEK-c-fos (Figure 
6.4B). To better control exogenous c-fos expression, the gene was cloned under the control 
of an acetaldehyde inducible promoter1.  However, also in that case it was observed a 
minimal benefit of c-fos (see Appendix 1, Section A1.2.5). 
                                                 
1 More details about the system are reported in the Appendix 1 
Chapter 6 – Overexpression of transcription and growth factors enhances TGE in CHO cells 
 88 
Control c-Fos
0
5
10
15
20
A
B
Ig
G
 [m
g/
L]
 
 
Figure 6.4. Effect of stable overexpression of c-fos on TGE. Pools of CHO cells stably 
expressing c-fos  (c-fos) or GFP (Control) were transfected with pXLGHEK-RhLC and pXLGHEK-
RhHC (mass ratio of 50:50). (A) At 3 days post-transfection IgG yields were quantified by ELISA. 
Error bars represent the standard deviation from two parallel experiments. (B) At 3 days post-
transfection, 5 million cells were harvested from each transfection and lysed. Each lysate was 
analyzed by immunoblot for the expression of c-fos using a polyclonal antibody anti human c-fos 
(Chapter 2, section 2.16).  
 
 
 
6.2.4 Effect of overexpression of growth factors on TGE yields 
 
To determine the effect of growth factors on TGE, vectors constructed with the 
cDNAs of different growth factors2 (10% of the total DNA) were co-transfected in CHO 
cells with a mix (90% of the total DNA) of pXLGHEK-RhLC, pXLGHEK-RhHC, and 
pXLGHEK-EGFP (at a mass ratio of 49:49:2). The control transfections were performed by 
replacing the growth factor vectors with pXLGHEK.  IgG expression was quantified by 
ELISA at 3 and 6 days post-transfection. By 3 days post-transfection, none of the 
exogenous growth factors demonstrated an enhancement of IgG yield (Figure 6.5). By 6 
                                                 
2 The vectors were kindly provided by Dr. Gaurav Backliwal (14;15) 
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days post-transfection, the culture transfected with pMYKEF1-aFGF yielded ~17 mg/L of 
IgG while the yields of the other transfections were less than 3 mg/L (Figure 6.5).  
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Figure 6.5. Effect of overexpression of growth factors on TGE yield. Cells were transfected 
with a mixture containing 10% of plasmid carrying a growth factor gene and 90% of a mix of 
pXLGHEK-RhLC, pXLGHEK-RhHC, and pXLGHEK-EGFP (at a mass ratio of 49:49:2). For the control 
transfection, pXLGHEK was substituted for the growth factor vector.  Antibody concentration in the 
medium was measured 3 and 6 days post-transfection. The error bars represent the standard 
deviation from two parallel experiments. 
 
 
 
 
To find the optimal amount of aFGF plasmid for transfection, CHO cells were 
transfected with varying amounts of the vector (0 to 30% of total DNA) and a mix of 
pXLGHEK-RhLC, pXLGHEK-RhHC, and pXLGHEK-EGFP (mass ratio of 49:49:2) (70% of 
the total DNA). If necessary, the DNA was increased to 100% by addition of pXLGHEK. At 
3 days post-transfection, the transient IgG yields were quantified by ELISA. The highest 
concentration of IgG was observed when pMYKEF1-aFGF amount of 5% of the total 
DNA. Further increases in the amount of the aFGF vector resulted in decreased 
recombinant protein production (Figure 6.6A). The presence of aFGF in the supernatant 
was confirmed by immunoblot with a monoclonal antibody against aFGF (Figure 6.6B). 
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Figure 6.6. Optimization of pXLGHEK-aFGF amount for transfection. Cells were transfected with 
a mixture containing 0-30% of pMYKEF1-aFGF and 70% of a mix of pXLGHEK-RhLC, pXLGHEK-
RhHC, and pXLGHEK-EGFP (mass ratio of 49:49:2). The total DNA was made 100% by addition of 
pXLGHEK, as needed. (A) Antibody concentration in the medium was measured 3 days post-
transfection by ELISA. The error bars represent the standard deviation from two parallel 
experiments. (B) The presence of aFGF in the supernatant at 3 days post-transfection by 
immunoblot using an anti-human aFGF monoclonal antibody (Chapter 2, Section 2.16).  
 
 
 
6.2.5 Co-cultivation of cells transiently expressing IgG and cells 
transiently expressing aFGF 
 
As another approach to increase the TGE yield by aFGF treatment, CHO cells were 
separately transfected with pMYKEF1-aFGF and added to a culture of cells transiently 
transfected with a 1:1 mix (w/w) of pXLGHEK-RhLC and pXLGHEK-RhHC. In this way, the 
amounts of IgG light and heavy chain vectors in the transfection were increased as 
compared to the transfections reported in the previous section.  Since aFGF can function in 
a paracrine manner, it was expected to enhance the TGE yield even if not expressed from 
the same cells as the recombinant IgG (Figure 6.7) (8). 
CHO cells were transiently transfected with either pMYKEF1-aFGF or a mix of 
pXLGHEK-RhLC and pXLGHEK-RhHC as described above. At 4 h post-transfection 
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different amounts of CHO cells transiently expressing aFGF were mixed with CHO cells 
expressing IgG. Antibody yields were quantified at 6 days post-transfection and aFGF 
expression was confirmed by immunoblot. The highest IgG yields were observed in 
cultures in which 20% of the cells expressed aFGF (Figure 6.8). 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.7. Schematic diagram of the co-cultivation strategy. Cells are transfected with the 
gene of interest (GOI) vector and mixed with cells transiently transfected with pMYKEF1-aFGF. 
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Figure 6.8. Effect of co-cultivation of cells transiently expressing aFGF on TGE yields.  Cells 
were transfected either with pXLGHEK-RhLC, pXLGHEK-RhHC (mass ratio of 50:50) or with 
pMYKEF1-aFGF. Four hours after transfection, different amounts of cells expressing aFGF were 
added to cells transiently producing IgG. (A) Antibody yields were quantified 6 days after 
transfection and reported as fold increase compared to the control (0% of cells transiently 
producing aFGF). The error bars represent the standard deviation from two parallel experiments. 
(B) aFGF expression was confirmed by immunoblot as described in Figure 6.6.  
aFGF 
GOI 
aFGF expression 
TGE GOI 
↑↑ GOI expression 
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6.2.6 Co-cultivation of cells transiently expressing IgG and cells stably 
expressing aFGF 
 
To extend the strategy described in the previous section, pooled CHO cells stably 
expressing aFGF were co-cultivated with cells transiently transfected with pXLGHEK-
RhLC, pXLGHEK-RhHC vectors (mass ratio of 50:50). Cell pools stably expressing GFP 
were used as a control. IgG yields increased as the percentage of aFGF-expressing cells 
increased (Figure 6.9). As expected, the transient IgG yields decreased as the percentage of 
cells stably expressing GFP increased (Figure 6.9). 
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Figure 6.9. Transient IgG production from CHO cells co-cultured with stable pools 
expressing aFGF or GFP. Cells were transfected with pXLGHEK-RhLC, pXLGHEK-RhHC (mass 
ratio of 50:50). At 4 h post-transfection different amounts of cells stably expressing either aFGF or 
GFP were added to the transfected cell population. The IgG concentration was determined at 6 
days post-transfection by ELISA. The error bars represent the standard deviation from two parallel 
experiments. 
 
 
The experiment was then repeated with several clonal cell lines stably expressing 
aFGF. Each cell line was co-cultured with CHO cells transfected with pXLGHEK-RhLC, 
pXLGHEK-RhHC (mass ratio of 50:50). The final percentage of the aFGF expressing clones 
in the culture was 20%. At 6 days post-transfection, the transient IgG concentration was 
quantified by ELISA. Most of the the samples treated with the clones showed an 
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improvement on IgG titers (Figure 6.12A) and the enhancement seemed to correlate with 
the aFGF amount in the culture (Figure 6.10). 
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Figure 6.10. Transient IgG production from CHO cells co-cultured with clonal cell lines 
expressing aFGF. Cells were transfected with pXLGHEK-RhLC, pXLGHEK-RhHC (mass ratio of 
50:50). At 4 h post-transfection the transfected cells were mixed with different CHO-derived cell 
lines expressing aFGF. The final percentage of the aFGF expressing clones was 20%. The control 
sample was a stable clone over-expressing GFP. (A) The recombinant IgG concentration was 
determined at 6 days post-transfection by ELISA. The error bars represent the standard deviation 
from two parallel experiments. (B) aFGF expression from each cell line was analyzed by 
immunoblot after 3 days of culture as described in Figure 6.6. 
 
 
 
6.2.7 Effect of VPA or hypothermia on TGE in the presence of cells 
stably expressing aFGF  
 
The influence of VPA and hypothermia on TGE yields in CHO cells has been 
described (Chapters 4 and 5).  Here the possible synergistic effect on TGE yields of each 
of these treatments in the presence of aFGF was investigated. CHO cells were transfected 
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with a mix of DNAs containing pXLGHEK-RhLC and pXLGHEK-RhHC at a mass ratio of 
50:50. At 4 h post-transfection, cells stably expressing aFGF as described above were 
added to a final cell concentration of 20% of the total. Cells were then treated with 2.5 mM 
VPA or shifted to 31°C. The control transfection was treated with VPA or incubated at 
31°C without the addition of stable aFGF-expressing cells. IgG yields were quantified by 
ELISA at 6 days post-transfection.  The presence of aFGF in the culture had the greatest 
effect when the cells were not treated with VPA or exposed to hypothermic conditions 
(Figure 6.11). Under hypothermic conditions and in the presence of VPA, the presence of 
aFGF did not have a significant impact on the recombinant IgG yield (Figure 6.11).  
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Figure 6.11. Transient IgG production from CHO cells co-cultured with pools expressing 
aFGF either under hypothermic conditions or after VPA treatment. Cells were transfected with 
pXLGHEK-RhLC and pXLGHEK-RhHC (mass ratio of 50:50). At 4 h post-transfection the transfected 
cells were mixed with cells stably expressing aFGF to a final concentration of 20% of the total cells. 
The control samples were not mixed with cells expressing aFGF. The recombinant IgG production 
was quantified by ELISA at 6 days post-transfection. Transfected cells were maintained at 37°C 
(1), maintained at 31°C (2), or maintained at 37°C and treated with 2.5 mM VPA. The error bars 
represent the standard deviation from two parallel experiments. 
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6.3    Discussion and conclusions 
 
In this chapter two strategies for increasing TGE in CHO cells by enhancing transgene 
transcription were presented. Transcription factors and growth factors able to activate 
transcription of transgenes controlled by the immediate early cytomegalovirus 
promoter/enhancer were screened for their ability to increase transgene transient 
recombinant IgG production (3-7). Among the transcription factors tested, c-fos, c-jun, and 
NF-kB were the ones that increased TGE yields to the greatest extent. Among the growth 
factors tested, only aFGF was able to improve TGE yields.  
Transient overexpression of the three transcription factors mentioned above in addition 
to Sp1 increased transient IgG and GFP mRNA and protein levels. In contrast, the transient 
overexpression of CREB or Elk1 did not increase TGE yields.  It was recently reported that 
the induction of c-fos, c-jun or NFkB expression by doxorubicin increased the production 
of transgenes under the control of the immediate early CMV promoter/enhancer (4;5).  The 
addition of VPA to the cells co-transfected with transcription factor genes had a synergistic 
effect on TGE yields. Similar effects of VPA and NaBut on recombinant protein 
production in CHO cells have previously been reported (16).  In the presence of VPA cells 
overexpressing c-fos or c-jun produced ~90 mg/L of recombinant antibody by 6 days post-
transfection.   
Based on the results from transient expression of transcription factors, it was decided 
to try to develop an engineered CHO line that stably overexpressed c-fos from either a 
constitutive promoter. However, the benefit for TGE yields from constitutive c-fos 
expression was not as great as that observed in cells transiently producing c-fos. It is 
possible that the constitutive expression of c-fos had a negative impact on the cells. For 
this reason, c-fos was also transiently expressed from a gas inducible promoter (17;18). 
However, the enhancement of TGE yields after the induced expression of c-fos was not as 
high as in the cells co-transfected with a vector that constitutively expressed c-fos.  
The second strategy to increase TGE yields involved the co-expression of growth 
factors. Those chosen were ones that were expected to activate the transcription of NFkB, 
c-fos and c-jun (9-11). aFGF showed the highest improvement on protein transient protein 
production as previously reported (14). To eliminate the need to co-transfection with the 
aFGF vector, stable cell lines overexpressing aFGF were generated and co-cultured with 
transiently transfected CHO cells. In this experiment, transient IgG production was 
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enhanced by the presence of aFGF and the transient recombinant protein yield correlated 
with the amount of aFGF in the medium.  
Both the approaches proposed in this chapter were found to increase transient 
recombinant protein production in CHO cells, but the yields were significantly lower 
compared to the ones reported after hypothermic shift (Chapter 4) or VPA treatment 
(Chapter 5). For the transcription factors tested, only the combination of VPA addition in 
presence of transient c-fos or c-jun expression resulted in comparable IgG yields to those 
reported in Chapters 4 and 5. However, similar yields were also reached with the 
combination of VPA and hypothermia, a simpler and more reproducible  strategy 
compared to overexpression of a transcription factor either transiently or in an engineered 
cell line. VPA was also found to increase the TGE yields from cultures treated with aFGF; 
however, the benefit of the presence of aFGF was minimal compared to the effect of VPA 
alone. Since recombinant aFGF can be purified and used as media additive, further 
developments may be possible by adding it to transiently transfected CHO cells treated 
with VPA.  
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Chapter 7 
Conclusions and perspectives 
 
 
 
7.1 Conclusions 
 
Transient gene expression is a fast and easy method to produce recombinant proteins. 
Until now, however, the average yields produced by TGE have been modest compared to 
those obtained by SGE. The highest reported yields achieved in CHO cells were ~10-20 
mg/L (1-4). Improvements in protein production by TGE have recently been reported, and 
it was possible to achieve almost 1 g/L of recombinant antibody using HEK293 cells 
culture in high cell and treated with VPA  and cell cycle arrest genes (5).  
The work described here was aimed at finding methods to enhance the productivity of 
TGE processes in CHO cells. The major bottleneck for recombinant protein expression 
was identified as the transgene mRNA level. Increasing the quantity of DNA used for 
transfection did not increase mRNA levels or recombinant protein yields.  Instead, the 
amount of protein produced correlated with the amount of the transgene mRNA. It was 
also reported here that the recombinant protein yield was vector dependent and that the 
steady-state transgene mRNA level decreased within 3 days post-transfection. Therefore, 
three different strategies based on increasing and stabilizing transgene mRNA levels were 
proposed and analyzed. 
(I) Hypothermia was shown to modify cell metabolism, block cell cycle and 
increase transgene mRNA levels. It is not clear if all those phenomena act 
together in a synergistic way, however, significant improvements on 
recombinant protein yields were achieved after hypothermic shift of transiently 
transfected CHO cells to 31 °C. Moreover, for the first time it was reported that 
the steady-state transgene mRNA level under hypothermic conditions was 
Chapter 7 – Conclusions and perspectives 
 
 100 
stabilized over time. The extent of the increase in recombinant protein yield 
was also partly dependent on the expression vector used for transfection and on 
the protein expressed.  
(II) Similar results were obtained with the treatment of transiently transfected CHO 
cells with VPA, a histone deacetylase inhibitor. In the presence of VPA, cell 
growth was slowed and the steady-state transgene mRNA level was higher and 
more stable over time as compared to the control transfection, leading to an 
increase in protein production up to 60 mg/L. Again, the extent of the yield 
increase was dependent on the plasmid used; the expression vectors with a 
viral promoter were more sensitive to VPA treatment. 
(III) The third strategy proposed for increasing the transgene mRNA level was the 
over expression of transcription factors and growth factors. Among the factors 
tested, only c-fos, c-jun, NF-kB and aFGF were able to increase recombinant 
protein expression. However, the amount of recombinant protein produced was 
lower compared to the yields obtained with the other two strategies.  
By combining different strategies the recombinant protein production achieved the 
highest yield ever reported for a TGE process in CHO cells - 90 mg/L. This result was 
obtained in the presence of VPA in combination with hypothermia or by overexpressing c-
fos in the presence of VPA. However, the first approach appeared to be a better approach 
to increase recombinant protein production in CHO cells because it is a simpler, more 
reproducible and less expensive method compared to the overexpression of a transcription 
factor. 
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7.2 Perspectives 
 
The strategies investigated here improved TGE in CHO cells. However there are still 
some key areas that need to be addressed: 
• It is essential to have a better understanding of the effects of VPA and/or 
hypothermia on the transfected cells. It appeared that they both act at the level of 
transcription or mRNA stability but the exact mechanism(s) is not known.  
o It has been reported that under hypothermic conditions, the cell’s siRNA 
and miRNA machinery is modified (6). Therefore, the siRNAs and miRNAs 
that may affect transgene expression in CHO cells should be quantified.  
Small RNAs are not only directly responsible for transcript cleavage (7) but 
they are also involved in epigenetic regulation of the gene (8). 
o Another strategy to understand the molecular mechanism(s) behind 
hypothermia and VPA treatment are DNA microarrays. The comparison of 
the transcriptomes of untreated cells and cells cultured either under 
hypothermic conditions or with VPA may provide information about the 
genetic regulation in the treated samples. Unfortunately, cDNA microarrays 
specific for CHO cells are still under development. qRT-PCR targeting 
specific genes (i.e. those involved in cell cycle or in DNA silencing) could 
be used as alternative strategy. 
o Epigenetic silencing of the transfected pDNA should be analyzed. It was 
reported that the extent of the response to hypothermia or to VPA was 
vector dependent. If epigenetic regulatory mechanisms are involved in TGE, 
then the extent of plasmid DNA methylation and histone modification, 
especially acetylation, should be determined on the promoter/enhancer 
elements of different expression vectors used for transfection. 
• The possibility to increase TGE in CHO cells to the g/L level as has been achieved 
in HEK 293 cells should also be investigated. Performing the transfections at 
higher cell densities combined with hypothermia and VPA in fed-batch processes 
is expected to further improve on the yields reported here. 
• Engineering a host cell line overexpressing a transcription factor or a growth factor 
may not be the best strategy to increase TGE yields. An alternative strategy is the 
induction of endogenous transcription factors by addition of small molecules such 
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as doxorubicin to the culture medium (9;10). However, the benefit/cost issue 
should be taken in account when using this approach. 
• It has been presented that the level and stability of transgene mRNA is one of the 
main bottlenecks for transient recombinant protein production in CHO cells. It 
would be interesting to investigate if this phenomenon also occurs in transiently 
transfected HEK 293 cells. If VPA has the same effect both in CHO and in HEK 
293 cells, then a comparative study may yield clues as to how VPA transient 
recombinant protein production.  
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Appendix 1 
Set up of a gas inducible system 
for transient gene expression in 
CHO cells 
 
 
 
A1.1   Introduction 
 
The acetaldehyde inducible expression system developed by the Weber et al. (1-3) 
takes advantage of the natural ability of the fungus Aspergillus Nidulans of surviving in the 
presence of ethanol as its sole carbon source (Figure A1.1). Ethanol is oxidized into 
acetaldehyde by alcohol dehydrogenase (ADH), and the acetaldehyde is converted into 
acetate by aldehyde dehydrogenase (ALDH). Acetate is then converted into acetylCoA and 
can enter the Krebs’ cycle. In the presence of acetaldehyde, the AlcR (Acetaldehyde 
receptor) transactivator binds specific operators to induce the expression of its own cistron 
as well as the transcription of the two enzymes (ADH and ALDH) necessary for survival  
(4).  The ADH promoter (AlcP) harbours several elements (OAlcA) with high affinity for 
AlcR (1;4). Based on these observations, two vectors were created to create a gas inducible 
system for regulated gene expression in mammalian cells (1). pWW195 (see Fig. 2.8) has 
the AlcR gene under the control of the SV40 early promoter. pWW192 (Fig. 2.8) allows 
the cloning of the gene of interest under the control of the PAIR promoter. PAIR is composed 
of eight A. Nidulans PAlcA-derived modules and a minimal version of the human CMV 
promoter (hCMVmin). Thus, transfection of cells with both plasmids followed by induction 
with acetaldehyde results in induction of GOI expression. Without induction, GOI 
expression is minimal (Figure A1.2).  
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Figure A1.2. Schematic diagram of acetaldehyde inducible gene expression in Aspergillus 
Nidulans. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure A1.2.  Schematic diagram of acetaldehyde inducible gene expression in a mammalian cell. 
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A1.2   Results 
 
 
A1.2.1 Optimization of pWW195:pWW192 ratio 
 
Initial tests to apply the acetaldehyde inducible system to TGE in CHO DG44 cells 
employed GFP as a reporter protein. CHO DG44 cells were transfected with 
pWW192eGFP and pWW195 at different ratios. The cultures were treated with 20 mg/mL 
of acetaldehyde and GFP expression was measured two days after induction. The highest 
level of GFP-specific fluorescence was recorded when cells were transfected with 60% of 
pWW195 and 40% of pWW192eGFP (Figure A1.3). 
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Figure A1.3. Optimization of pWW195-pWW192eGFP ratio for TGE in CHO DG44 cells. Cells 
were transfected with pWW195 and pWW192eGFP at different ratios as indicated. Cells were 
induced with acetaldehyde and GFP-specific fluorescence was measured at 2 days post-induction. 
The error bars represent the standard deviation from two parallel experiments. 
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A1.2.2 Optimization of Acetaldehyde concentration 
 
To quantify the optimal acetaldehyde concentration for the induction, CHO DG44 
cells were transfected with pWW195 and pWW192eGFP at a 60:40 ratio and induced with 
increasing amount of acetaldehyde. GFP-specific fluorescence was measured 2 days after 
induction. The acetaldehyde concentration from 20 to 100 mg/mL increased GFP 
expression of 6-7 fold over the uninduced control (Figure A1.4 - left and right panels). 
High levels of acetaldehyde (> 100 mg/mL) were toxic for the cells. In fact, GFP 
expression and cell viability decreased proportionally with the increase of the acetaldehyde 
concentration (Figure A1.4 - right panel). GFP-specific fluorescence and cell viability 
levels reached zero for acetaldehyde concentrations of 250 mg/mL and higher. 
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Figure A1.4. Effect of acetaldehyde on gene induction (left and right panels) and cell viability (right 
panel). CHO DG44 cells were transfected with pWW195:pWW192GFP at a ratio of 60:40 (w/w). 
Liquid acetaldehyde was added to each culture to reach the concentrations indicated. Two days 
after induction cells were harvested, and GFP expression and cell viability were quantified. Error 
bars represent the standard deviation from two different experiments. Differences between the two 
expression levels were due to two different batches of medium used for transfection. 
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A1.2.3 Optimization of the time of induction  
 
In transient gene expression timing can have a big impact on protein expression. 
Therefore it was important to set up when the transfected cells can be induced. We 
excluded the addition of Acetaldehyde during transfection, in order to avoid any influence 
on transfection efficiency. CHO DG44 cells were transfected with pWW195 and 
pWW192eGFP as in the previous section.  Acetaldehyde was added either at the time of 
dilution (4 h post-transfection) or at 24 h after transfection. Based on the level of GFP-
specific fluorescence at 2 days post-induction, the better time for  induction was 4 h post-
transfection (Figure A1.5). 
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Figure A1.5. Effect of time of acetaldehyde addition on level of GFP expression.  CHO DG44 cells 
were transfected with pWW195:pWW192GFP at a ratio 60:40 (w/w). Acetaldehyde was added to a 
final concentration of 20 mg/mL at either 4 h (black bars) or 24 h (gray bars) post-transfection. Two 
days after induction, the level of GFP-specific fluorescence was quantified. Error bars represent the 
standard deviation from two parallel experiments.  
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A1.2.4 Kinetics of GFP expression after induction 
 
Finally, GFP expression was analyzed at various times after induction to determine 
both the time of its highest level of accumulation and the reversibility of the inducible 
system. CHO DG44 cells were transfected with pWW195 and pWW192eGFP at a 60:40 
ratio (w/w) and induced with 20 mg/mL acetaldehyde. Each day after induction, GFP-
specific fluorescence was measured. The highest level of GFP expression was reached at 
48 h after induction and then decreased over time, demonstrating the reversibility of the 
inducible system (Figure A1.6).   
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Figure A1.6. Kinetics of transient GFP expression after induction with acetaldehyde. CHO DG44 
cells were transfected with pWW195:pWW192GFP at a ratio of 60:40 (w/w). At 4 h after 
transfection, 20 mg/mL of acetaldehyde were added. GFP-specific fluorescence was quantified at 
the times indicated. Error bars represent the standard deviation from two parallel experiments.  
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A1.2.5 Overexpression of c-fos from a gas inducible promoter  
 
CHO cells were transfected with pWW192c-fos (Chapter 2, section 2.3.7) and either 
induced or not with 20 mg/mL of acetaldehyde. Cell lysates were analyzed by immunoblot 
to determine the level of c-fos expression with a polyclonal antibody against c-fos. Cells 
transfected with pXLGHEK-c-fos were used as positive control. As expected, the sample 
from the acetaldehyde-induced cells had a higher level of c-fos expression than the non-
induced one (Figure A1.7). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure A1.7. Inducible transient expression of c-fos. CHO cells were transfected with pXLGHEK-
c-fos (1) or pWW192c-fos (2,3).  The cultures transfected with the latter were left untreated (2) or 
induced with 20 mg/mL acetaldehyde (3). Three days after transfection, 5 million cells were 
harvested, and total intracellular proteins were extracted and analyzed by immunoblot to detect c-
fos using a polyclonal antibody anti human c-fos (Chapter 2, section 2.16).  
 
 
 
CHO cells were transfected with pWW192c-fos, pXLGHEK-c-fos, or pXLGHEK.  At 4 h 
post-transfection 20 mg/mL of acetaldehyde were added to each culture. At 2 days post-
induction, the cells were transfected with pXLGHEK-RhLC, pXLGHEK-RhHC, and 
pXLGHEK-EGFP (mass ratio of 49:49:2), and 6 days after the second transfection, the 
recombinant IgG concentration was quantified by ELISA. Despite the very low IgG yields 
in this experiment, the cells transfected with pWW192c-fos expressed almost 2-fold more 
antibody than the control which lacked exogenous c-fos overexpression (Figure 6.6).  The 
highest IgG yield, however, was observed in the culture transfected with pXLGHEK-c-fos 
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(Figure A1.8). In this experiment double-transfections were used in order to transfect cells 
with the c-fos vector and then induce them prior to the second transfection with the IgG 
vectors. The double transfection may result in cell stress that prevented higher TGE yields. 
Therefore, it may be suitable to try establishing a stable cell line that can be induced to 
express c-fos. 
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Figure A1.8. Effect of c-fos overexpression on TGE.  CHO cells were transfected with pXLGHEK 
(1), pWW192c-fos (2), or pXLGHEK-c-fos (3). Four hours after transfection all samples were induced 
with   20 mg/mL of acetaldehyde. Two days after transfection, cells were transfected with pXLGHEK-
RhLC, pXLGHEK-RhHC, and pXLGHEK-EGFP (mass ratio of 49:49:2). Six days after the second 
transfection, IgG yields were quantified by ELISA. Error bars represent the standard deviation from 
two parallel experiments, 
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Appendix 2 
Partial characterization of a 
recombinant antibody 
 
 
 
A2.1   Introduction 
 
The reporter protein used in all the experiments reported in this thesis was the anti-
Rhesus D recombinant IgG antibody. Antibodies are globular proteins, with a molecular 
weight of ~160 KDa. They are composed by two heavy chains of ~55 KDa and two light 
chains of ~25 KDa. The light and heavy chains are bound together by disulphide bridges. 
The heavy chains present an N-glycosylation site on Asn297. A complete characterization 
of the recombinant product should include the use of several preparative and analytical 
methods summarized below: 
(I) purification by affinity, ion exchange and size exclusion chromatography 
(II) SDS-PAGE gel and isoelectrofocusing (IEF)  
(III) analytical chromatography (size exclusion/reverse phase/ion exchange) to 
determine the purity of the sample 
(IV) N-terminal sequencing (Edman degradation) to identify possible N-terminal 
truncations 
(V) Elman assay to check the thiols content 
(VI) Amino acid analysis as an additional check for purity 
(VII) peptide mapping on the intact protein and on impurities present in the reverse 
phase or ion exchange chromatograms 
(VIII) glycosylation profile analysis by HPLC/capillary electrophoresis/HPLC-MS 
Since our laboratory is not equipped with all of these analytical tools, only a partial 
characterization of the recombinant antibody was performed and reported.  
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A2.2 Results 
 
 
A2.2.1 UV spectrum 
 
The IgG was purified by affinity chromatography and desalted as reported in Chapter 
2, Section 2.13. To determine the concentration of the purified protein and to evaluate the 
purity, the sample was analyzed by UV spectroscopy from 220 to 350 nm (Figure A2.1) 
using a Nanodrop ND-1000 spectrophometer (Witeg, Littau, Switzerland). The ratio 
between the absorbance at 260 nm and 280 nm was ~0.5, meaning that the sample was not 
contaminated by DNA. The total amount of protein contained in the sample was 
determined to be 0.53 mg/mL using the Lambert Beer equation and considering the 
extinction coefficient (ε, L•mol-1•cm-1) equal to 146,400 (1). 
 
 
 
 
Figure A2.1. UV spectrum of the purified IgG. Recombinant human IgG was purified by affinity 
chromatography as described in Chapter 2, Section 2.13. After desalting, the sample was analyzed 
by UV spectroscopy in the range of 220 and 350 nm using a Nanodrop ND-1000 
spectrophotometer. 
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A2.2.2 Size exclusion chromatography 
 
To check for the presence of IgG aggregates or other impurities, the sample was 
analyzed by size exclusion chromatography using a Superose 12-HR column (GE 
Healthcare, Otelfingen, Switzerland) and an ÄKTA-FPLC system with a 280 nm UV 
detector (GE Healthcare). The sample was eluted isocratically at 1 mL/min using a mobile 
phase composed of 50 mM sodium phosphate and 50 mM NaCl at pH 7.20. 
Retention times of proteins with known molecular weight were calculated using the 
Unicorn Software v.4.0 (GE Healthcare) and then used to create a standard curve. The 
retention time of the sample was calculated after integration of the chromatogram with the 
Unicorn Software v.4.0 (Figure A2.2) and fitted to the standard curve previously created in 
order to obtain the molecular weight of the protein. The molecular weight of ~164 KDa 
from the standard curve correlated with the predicted molecular weight. 
From the chromatogram it was also observed that the peak was wide and tailed, 
suggesting that the sample contained different molecular weight species (Figure A2.2).  
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Figure A2.2. Size exclusion chromatography of the purified recombinant IgG. Recombinant 
human IgG was purified by affinity chromatography as described in Chapter 2, Section 2.13. After 
desalting, 250 μL of the sample were injected in a Superose 12-HR column and eluted isocratically 
as described in the text. The retention time was calculated after integration of the chromatogram 
with the Unicorn Software and fitted in a standard curve in order to obtain the molecular weight of 
the protein. 
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A2.2.3 SDS-PAGE 
 
As a second measure of sample purity and also for molecular weight analysis, the 
purified protein was analyzed by SDS-PAGE using 4-12% gradient gels (Invitrogen). The 
sample was treated at 95°C for 5 min in either non-reducing or reducing sample buffer 
(Chapter 2, Section 2.16) and loaded in the gel. After electrophoresis, the gel was stained 
with Coomassie Blue. 
The sample electrophoresed under reducing conditions migrated as two bands at 55 
KDa and 27 KDa corresponding to the molecular weights of IgG heavy and light chains, 
respectively (Figure A2.3A). The sample electrophoresed under non-reduced conditions 
showed a major species that migrated with an apparent molecular weight of ~160 KDa, 
correlating with the IgG molecular weight (Figure A2.3B). On the same gel, two or more 
minor species migrating at lower molecular weights were visible. It was not possible to 
clearly identify these minor species. However, western blot analyses using either an anti-Fc 
or an anti-light chain antibody identified these fragment as IgG (data not shown). Since 
under reducing conditions only two protein species were observed it is possible that the 
antibody encountered reducing degradation either in cells or in the cell culture medium 
after secretion. 
 
 
      
 
 
 
 
 
 
 
 
 
Figure A2.3. SDS-PAGE of the purified recombinant IgG. Recombinant human IgG was purified 
as described in Chapter 2, Section 2.13. After desalting, samples were treated at 95°C for 5’ with 
reducing (A) or non-reducing (B) sample buffer and electrophoresed in a 4-12% gradient gel. The 
gel was stained with Coomassie Blue. 
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A2.2.4 Deglycosylation with PNGase F 
 
The extent of the heavy chain glycosylation was estimated by SDS-PAGE with 4-12% 
gradient gels (Invitrogen). Recombinant antibody transiently produced at 31 °C or 37 °C 
was partially purified by affinity chromatography and then treated for 12 hours at 37 °C 
with peptide-N-glycosidase F (PNGase F). PNGase F is a deamidase and it is one of the 
most widely used enzymes for the deglycosylation of glycoproteins. The enzyme releases 
asparagine-linked (N-linked) oligosaccharides from glycoproteins and glycopeptides (2).  
Samples were treated at 95°C for 5 min in reducing sample buffer (Chapter 2, Section 
2.16) and electrophoresed. The gel was stained with Coomassie Blue. The IgG heavy chain 
had about 3 kDa of glycosylation judging from the band shift after PNGase F treatment 
(Figure A2.4). The difference in band intensity is due to the higher amount of purified 
antibody recovered from samples cultured at 31°C (Figure A2.4, lanes 3 and 4). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure A2.4. SDS-PAGE analysis of antibody glycosylation. Affinity purified antibody produced 
by TGE at 37°C (lanes 1-2) and 31°C (lanes 3-4) were deglycosylated with PNGase F. Protein 
samples before  (lanes 1 and 3) and after (lanes 2 and 4) treatment with PNGase F were 
electrophoresed on a 4-12% polyacrylamide gradient gel.  
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A2.3   Conclusions 
 
Even if the recombinant product was already identified as anti-Rhesus D antibodies 
from the ELISA analyses performed for quantification in the supernatant, from the 
analyses reported after purification it was possible to conclude that: 
(I) in the purified sample are present species of low molecular weight (less than 
160 kDa) that were also determined to be the recombinant antibody;  
(II) the recombinant antibody had 3 KDa of N-linked glycosylation on the heavy 
chain. 
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